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ABSTRACT 
 
Brooke E. Christian.  Mechanisms of Translational Initiation and Elongation in Mammalian 
Mitochondria 
(Under the direction of Linda L. Spremulli) 
Initiation of protein synthesis in mammalian mitochondria involves two protein 
factors: initiation factor 2 (IF2mt) and initiation factor 3 (IF3mt).  Mutations were designed in 
various domains of IF3mt to identify the functionally important regions.  Residues 170-171, 
and 175 in the C-terminal domain nearly abolished activity in initiation complex formation 
and in 55S ribosomal dissociation.  However, these mutated proteins bound to the 28S 
ribosomal subunit with Kd values similar to the wild-type factor.  The results suggest that 
IF3mt plays an active role in initiation of translation. 
Mammalian mitochondrial mRNAs have few or no nucleotides prior to the 5’ start 
codon.  Both the mammalian mitochondrial 55S ribosome and 28S subunit preferentially 
formed initiation complexes at a 5’ terminal AUG codon over an internal AUG.  The 
selection of the 5’ AUG depended on the presence of fMet-tRNA and was enhanced by the 
presence of IF2mt.  Addition of even a few nucleotides 5’ to the AUG codon significantly 
reduced the efficiency of translation.  In addition, very few initiation complexes could form 
on a hybrid mRNA construct consisting of the tRNAMet attached at the 5’ end to a 
mitochondrial protein coding sequence.  This observation demonstrates that post-
transcriptional processing must occur prior to translation in mammalian mitochondria. 
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Mutations in the nuclear genes for mammalian mitochondrial translational 
elongation factors are generally lethal shortly after birth.  A mutation of EF-Tsmt (R325W) 
resulted in a significant reduction in the ability of EF-Tsmt to bind EF-Tumt. A mutation of EF-
Tumt (R336Q) causes infantile encephalopathy arising from defects in mitochondrial 
translation.  The R336Q mutation caused a two-fold decrease ternary complex formation 
with E. coli aminoacyl-tRNA but completely inactivated EF-Tumt for binding to mitochondrial 
aminoacyl-tRNA. 
Polyamines are important in both prokaryotic and eukaryotic translational systems.    
Spermine stimulated fMet-tRNA binding to mammalian mitochondrial 55S ribosomes in a 
manner independent of the identity of the mRNA and to the same degree at all 
concentrations of IF2mt and IF3mt.  The major effect of spermine in promoting initiation 
complex formation appears to be on the interaction of fMet-tRNA with the ribosome. 
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MECHANISM OF PROTEIN SYNTHESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sections in this chapter have been published (1) and reprinted with permission.   
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Figure 1-1. Structure of a mitochondrion. The 
mitochondrial outer membrane is shown in 
dark blue, the inner membrane is shown in 
light blue, and the cristae are shown in 
yellow.  Image courtesy of Dr. G.A. Perkins 
(UCSD) and Dr. T.G. Frey (SDSU).  Figure 
obtained with permission from Dr. T.G. Frey. 
INTRODUCTION 
 Mitochondria are small, membrane-bound organelles found in eukaryotic cells that 
are responsible for the generation of 90% of the cell’s energy in the form of ATP.  
Mitochondria range in size from 0.5 – 10 µM in diameter.  Mitochondria contain an inner 
membrane that is highly invaginated (Figure 1-1).  The folds of the inner membrane create 
internal compartments known as christae and produce an additional compartment known 
as the intercristal space.  The boundary of the inner membrane is connected to the cristae 
membrane by narrow, tube-like 
structures that serve as barriers 
between the intracristal space and the 
intermembrane space (2).  The 
production of ATP occurs along the 
inner membrane, using the electron 
transport chain and ATP synthase.  The 
electron transport chain uses 
oxidation/reduction carriers to create a 
proton gradient across the inner 
mitochondrial membrane to drive the 
synthesis of ATP (Figure 1-2).  Four 
multi-subunit protein complexes and several mobile carriers (coenzyme Q and cytochrome 
c), compose the electron transport chain: Complex I (NADH: ubiquinone oxidoreductase, or 
NADH dehydrogenase), Complex II (Succinate: ubiquinone oxidoreductase, or succinate 
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Figure 1-2.  Electron transport chain.  Figure obtained from commons.wikipedia.org as 
a free public domain file.  Complexes are indicated by Roman numerals.  Q is 
coenzyme Q, and Cyt c is cytochrome c. 
dehydrogenase), Complex III (ubiquinone: cytochrome c oxidoreductase, or cytochrome 
reductase) and Complex IV (cytochrome c: oxygen oxidoreductase, or cytochrome oxidase).  
Although most proteins involved in the synthesis of ATP are synthesized in the cell 
cytoplasm and imported into the mitochondrion, thirteen are mitochondrially encoded and 
synthesized (3).  These proteins are very hydrophobic, and thus import into the 
mitochondrion would be difficult. 
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Figure 1-3.  Organization of the mitochondrial genome.  
Figure modified from mitomap.org. 
 Mitochondria are unique organelles, containing their own genome and protein 
synthetic machinery.  Mammalian mitochondria contain about 16 kilobase pairs of DNA (4).  
This genetic information encodes 2 ribosomal RNAs (rRNAs), 22 transfer RNAs (tRNAs), and 
13 proteins (Figure 1-3).   The DNA is circular and continuous; it lacks significant non-coding 
regions.  The proteins encoded in this genome include subunits ND1, ND2, ND3, ND4, ND4L, 
ND5, and ND6 of the 
NADH dehydrogenase 
complex, subunits CoI, 
CoII, and CoIII of the 
cytochrome oxidase 
complex, cytochrome b 
from complex III, and 
ATPase6 and ATPase8 of 
the ATP synthase complex.  
The mitochondrial 
genome codes for one 
tRNA for every amino acid 
and two tRNAs for serine and leucine.  The rRNAs coded for by the mitochondrial genome 
include the 12S rRNA of the small ribosomal subunit and the 16S rRNA of the large 
ribosomal subunit.  Mitochondrial DNA is transcribed into a long, polycistronic RNA, which is 
then cleaved into the appropriate mRNAs, tRNAs, and rRNAs.  The mRNAs are subsequently 
polyadenylated.  DNA sequences that code for the mitochondrial tRNAs exist between 
Intercristal space 
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almost all of the mitochondrial protein coding genes.  The “tRNA punctuation” model of 
mRNA processing states that cleavage of the tRNAs from between mitochondrial protein 
coding sequences results in mRNAs that are ready for translation (5).  This model accurately 
predicts the 5’ ends of human mitochondrial mRNAs that lie in between tRNA sequences, 
but it does not address the question of how the mRNAs for other proteins are processed.  
For example, the gene encoding CoIII is preceded by the gene encoding ATP6 instead of a 
tRNA.  Thus, cleavage of the polycistronic RNA precursor to release the CoIII mRNA requires 
a mechanism distinct from tRNA punctuation. 
 
PROKARYOTIC PROTEIN SYNTHESIS 
 Mitochondria have many features in common with prokaryotes, including antibiotic 
sensitivity, and structures and functions of protein factors, tRNAs, and ribosomes.  The 
endosymbiotic theory of mitochondrial origin suggests that a bacterial cell was taken in by 
another cell, and that the endocytosis of that bacterial cell provided the evolutionary 
advantage of respiration.  Since mitochondria are thought to have arisen from a bacterial 
cell, the process of translation in that organelle is often compared to translation in 
prokaryotes. 
 
Structure of the Prokaryotic Ribosome 
Escherichia coli ribosomes (70S) are complexes of RNA and protein containing 2/3 
RNA and 1/3 protein.  These ribosomes are 2.3 MDa in molecular mass and are composed 
of two subunits, a small and large subunit, which sediment at 30S and 50S, respectively.  
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Figure 1-4. Structure of the E. coli ribosome.  Images from PDB 3I1M (30S) and 3I1N 
(50S).  The rRNAs are shown in blue and the protein is shown in red. 
While the crystal structure of the Thermus thermophilus 70S ribosome has been solved at 
2.80 Å resolution (6), the E. coli 70S ribosome has only been solved at 3.5 Å resolution (7).  
The small ribosomal subunit (SSU) has an overall shape similar to that of a bird and contains 
body, head, neck, beak, and platform regions (Figure 1-4).  The SSU consists of 16S rRNA 
(1542 nucleotides) and 21 proteins, while the large subunit (LSU) consists of 5S rRNA (120 
nucleotides), 23S rRNA (2904 nucleotides), and 33 proteins.  The SSU is responsible for 
binding the mRNA and anticodon loop of the tRNA.  The LSU is shaped like a glove with 
three fingers extended.  Two of the “fingers” are composed of the LSU proteins L1 and 
L7/L12, respectively, and the middle “finger” (the central protuberance) is composed of 
several proteins and the 5S rRNA.  The LSU binds the aminoacyl end of the tRNA and is 
where the peptidyl transferase reaction is catalyzed.  The ribosome contains three tRNA 
binding sites:  the A-site, P-site, and E-site.  The A-site (aminoacyl-site) is the decoding site 
where the aminoacyl-tRNAs (aa-tRNAs) bind in response to codons exposed on the mRNA.  
The P-site (peptidyl-site) holds the peptidyl-tRNA prior to its transfer to the incoming amino 
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acid.  The E-site (exit-site) binds the deacylated tRNAs until their final release from the 
ribosome.  
 
Translational Initiation 
Prokaryotic translation can be divided into three stages: initiation, elongation, and 
termination/ribosome recycling.  Initiation of translation in E. coli involves three protein 
factors: initiation factor 1 (IF1), initiation factor 2 (IF2), and initiation factor 3 (IF3).  IF1 is an 
essential 71 amino acid protein whose exact function is unknown (8).  IF2 promotes the 
binding of the initiator tRNA (fMet-tRNA) to the P-site of the 30S ribosomal subunit and 
promotes the joining of the 30S and 50S ribosomal subunits (9).  In E. coli, IF3 is thought to 
have a number of roles.  These include (1) dissociating 70S monosomes into subunits by the 
preferential binding of IF3 to the small ribosomal subunit, (2) promoting the formation of 
initiation complexes, (3) proofreading initiation complexes by dissociating those with non-
canonical start codons, (4) promoting the shift of the start codon on the mRNA into the P-
site of the SSU, and (5) mediating the codon/anticodon interactions between the initiator 
tRNA and the mRNA (10-18). 
Many bacterial mRNAs contain a Shine-Dalgarno (SD) sequence in their 5’ 
untranslated regions.  This sequence (AGGAGG), or a variation of this sequence, is located 
about 8 nucleotides upsteam of the start codon, and has been shown to hydrogen bond 
with the anti-Shine-Dalgarno (ASD) region near the 3’ end of the 16S rRNA.  The ASD 
consists of nucleotides complementary to the SD sequence.  The SD/ASD interactions help 
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Figure 1-5. Schematic diagram of prokaryotic translational initiation. 
IF3IF2
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Pre-Initiation 
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30S Initiation 
Complex
70S Initiation 
Complex
GTP
GDP
50S
50S
specify the start codon and correctly position the mRNA on the ribosome for translation 
initiation. 
In the current model of bacterial initiation, E. coli 70S ribosomes are in equilibrium 
with their subunits, but the equilibrium strongly favors the 70S particle (Figure 1-5).  IF3 
binds the 30S subunit, preventing its association with 50S subunits.  In a random order of 
binding, IF1 and IF2:GTP, along with the fMet-tRNA and mRNA,  bind to the 30S subunit of 
the ribosome (19). A pre-initiation complex is formed when the SD sequence of the mRNA is 
recognized and bound by the SSU carrying the fMet-tRNA and all three initiation factors.  
When codon-anticodon interactions between the AUG start codon of the mRNA and the 
fMet-tRNA occur, a stable initiation complex is formed.  Efficient translation depends on the 
correct formation of this initiation complex, and initiation complex formation is the rate-
limiting step of translation.  IF1 and IF3 are released prior to, or at the time of, 50S subunit 
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binding.  The release of IF2 is coupled to GTP hydrolysis triggered by the 50S subunit, and 
leads to the formation of the 70S initiation complex.  This complex then proceeds to the 
elongation phase of translation. 
 
Translational Elongation 
Elongation in E. coli involves several factors and is represented by three basic steps:  
selection of the aa-tRNA, peptide bond formation, and translocation.  Initially, elongation 
factor Tu (EF-Tu) binds GTP and the aa-tRNA to form the ternary complex (20).  The ternary 
complex then binds to the A-site of the ribosome.  This process is preceded by the binding 
of EF-Tu to GTP and the aa-tRNA to form the ternary complex.  Selection of the correct 
ternary complex is carried out by codon:anticodon interactions in the A-site.  After EF-Tu 
delivers the aa-tRNA to the ribosome, it is released as an EF-Tu:GDP complex.  Elongation 
factor Ts (EF-Ts) binds to the EF-Tu:GDP complex and promotes the exchange of GDP for 
GTP to form the regenerated EF-Tu:GTP complex (21).  The peptidyl transferase center of 
the ribosome catalyzes peptide bond formation by transferring the growing polypeptide 
chain to the amino function of the aa-tRNA in the A-site (21).  Elongation factor G (EF-G) 
catalyzes the translocation step in which the deacylated tRNA and the peptidyl-tRNA are 
moved from the P-site to the E-site and the A-site to the P-site, respectively, to expose the 
ribosome to the next codon in the mRNA sequence (1).  The activities of E. coli EF-G are well 
studied, and, in most bacteria, this protein acts both during polypeptide chain elongation 
and termination. 
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Translational Termination and Recycling 
 Translational termination begins when the ribosome encounters one of three stop 
codons (UAA, UAG, or UGA) in the A-site.  The stop codon is recognized by one of two 
release factors: release factor 1 (RF1) recognizes UAA and UAG, and release factor 2 (RF2) 
recognizes UAA and UGA.  Either RF1 or RF2 binds to the A-site of the ribosome and triggers 
transfer of the peptide chain from the tRNA in the P-site to a water molecule, thus ending 
protein synthesis.  Release factor 3 (RF3) then binds to the ribosome and stimulates the 
release of the polypeptide chain and either RF1 or RF2. 
After translation termination, the ribosomes must be recycled in order to be used 
for another round of protein synthesis.  In prokaryotes, ribosome recycling involves a 
protein factor termed ribosome recycling factor (RRF).  RRF together with EF-G split the 70S 
ribosome into its subunits, releasing the deacylated tRNA and mRNA (1). 
 
MITOCHONDRIAL PROTEIN SYNTHESIS 
Structure of the Mitochondrial Ribosome 
 The structure of the bovine mitochondrial ribosome has been solved by cryo-
electron microscopy to a resolution of 13.5 Å (22).  The overall architecture of the 
mitochondrial ribosome is similar to its prokaryotic counterpart.  It is 2.7 MDa in molecular 
mass and is composed of a large (39S) and small (28S) subunit, which associate to make an 
intact (55S) ribosome.  Mitochondrial ribosomes are composed of 2/3 protein and 1/3 RNA, 
a ratio that is reversed from that of the prokaryotic ribosome.  The mitochondrial rRNA is 
coded for in the mitochondrial genome, but all mitochondrial ribosomal proteins are 
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A                  B 
 
Figure 1-6. Cryo-electron microscopy of the bovine mitochondrial ribosome.  The small 
(A) and large (B) ribosomal subunits are shown from the interface side.  RNA is shown 
in orange (SSU) and purple (LSU), and protein is shown in yellow (SSU) and blue (LSU). 
Figure provided by R. Agrawal. 
Central protuberance
L1 stalk L7/L12 stalk
encoded in the nuclear DNA and are subsequently imported into the mitochondria.  
Although the mitochondrial ribosome is larger in molecular weight than the prokaryotic 
ribosome, it has a lower sedimentation value, reflecting the lower rRNA content and a more 
porous structure.  Approximately half of the mitochondrial ribosomal proteins are homologs 
of those in the prokaryotic system, while the other half are unique to mitochondria. 
The SSU is composed of 12S rRNA (950 nucleotides) and 29 proteins (Figure 1-6).  It 
is also larger in size than the prokaryotic SSU.  Of the 29 proteins, S2, S5-S7, S9-S12, S14-18, 
and S21 have sequence homology with the SSU proteins in the bacterial ribosome.  Much of 
the rRNA found in the prokaryotic ribosome is missing, including the ASD region of the 16S 
rRNA.   
The LSU is composed of 16S rRNA (1560 nucleotides) and approximately 50 proteins 
and is larger in size than its prokaryotic counterpart.  It is missing several segments of RNA 
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that are present in the bacterial ribosome (Figure 1-6).  Twenty-eight of the LSU proteins 
have sequence homology with the LSU proteins of the bacterial ribosome.  Like the bacterial 
LSU, it is shaped like a glove with the L1 stalk, L7/L12 stalk, and the central protuberance.  
However, the mitochondrial LSU has an additional protein feature, named the LSU handle 
that extends from the central protuberance to the main body of the subunit.  It is located 
on the solvent side of the subunit and is hypothesized to function in place of the 5S rRNA 
found in the bacterial ribosome.  
 
Mitochondrial mRNAs 
An important difference between bacterial and mitochondrial translation initiation is 
the process by which the start codon on the mRNA is placed in the P-site of the ribosome.  
In prokaryotes, the SD sequence upstream of the start codon directs the small subunit to 
the correct AUG codon as described above (23).  Mitochondrial mRNAs are largely 
leaderless; therefore, the mechanism of the selection of the translational start site must be 
different from that in prokaryotes.   
Leaderless mRNAs, in addition to being translated in mitochondria, are also 
translated in bacteria and archaea, although each system has unique mechanisms reported 
for the initiation of leaderless messages.  In prokaryotes, it is unclear whether initiation of 
leaderless mRNAs occurs on intact 70S monosomes or on dissociated 30S subunits (24-26).  
It is important to note, however, that most of the studies performed in prokaryotes on 
“leaderless” mRNAs used sequences beginning with “GAUG,” since transcription by T7 RNA 
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polymerase is substantially more effective when G is the first nucleotide in the transcript.  
These “GAUG” mRNAs are arguably not actually leaderless. 
In the archaeal system, 2/3 of all mRNAs are leaderless, and of the mRNAs that 
contain leaders, few have SD sequences (27).  In contrast to other systems where 
alternative initiation codons can be used, archaeal leaderless mRNAs are only translated 
when an AUG start codon is present (28).  In addition, introduction of an internal AUG to a 
leaderless mRNA resulted in translation from both the 5’ AUG and the internal AUG, 
although it was not determined that initiation occurred on both AUG’s simultaneously (28). 
 
Mitochondrial Translation Initiation 
Translation of the mRNAs encoded by mitochondrial DNA requires the presence of a 
protein biosynthetic system that is distinct from that of the cell cytoplasm.  Not only are the 
ribosomes composed of more protein and less rRNA (Figure 1-6), but the initiation factors 
and tRNAs have some important differences.  E. coli has separate initiator and elongator 
tRNAs for methionine, while mitochondria only have one that functions in both processes.  
Mitochondria also have the ability to use alternative start codons for translation initiation: 
AUA, AUC, and AUU, in addition to the canonical AUG start codon. 
Translation initiation factors have similarities in the bacterial and mitochondrial 
systems, but several key differences are apparent.  Three essential translation initiation 
factors have been identified in E. coli, while only two have been identified in the 
mitochondrial system.  In E. coli, IF2 promotes the binding of fMet-tRNA to the P-site of the 
30S ribosomal subunit and promotes the joining of the 30S and 50S ribosomal subunits (9).  
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Mitochondrial IF2 (IF2mt) appears to have the same fundamental activities found in its 
bacterial counterpart.  IF1 is an essential protein in E. coli, but its precise function is 
unknown (8).  No factor corresponding to IF1 has been identified in mitochondria.  
However, IF2mt has a 37 amino acid insertion that is believed to function in place of IF1 in 
translation (29).  Mitochondrial IF3 (IF3mt), like bacterial IF3, stimulates initiation complex 
formation by providing a pool of free 28S subunits for initiation (Figure 1-7).  IF3mt has the 
unique role not present in E. coli IF3 of reducing the IF2mt-mediated binding of fMet-tRNA to 
28S subunits in the absence of mRNA (30).  This observation suggests that mRNA binding 
normally precedes fMet-tRNA binding in the mitochondrial system. 
 
Mitochondrial Translation Elongation, Termination, and Ribosome Recycling 
Translation elongation and termination in mitochondria are very similar to the 
respective processes in E. coli.  Following translation initiation, the elongation step begins 
when EF-Tumt:GTP delivers the aa-tRNA to the A-site of the ribosome (Figure 1-7).  EF-Tsmt 
regenerates the EF-Tumt:GTP from EF-Tumt:GDP.  EF-G (EF-G1mt in the mitochondrial system) 
catalyzes the translocation of the tRNAs and the movement of the mRNA to expose the next 
codon in the A-site. 
Mitochondrial elongation factor Tu (EF-Tumt) is a 45.1 kDa protein that is 56% 
identical in sequence to E. coli EF-Tu (31).  EF-Tumt is composed of three domains, of which 
domain I contains the guanine nucleotide binding site.  All three domains are involved in 
binding to the aa-tRNA (32).  Domain 1 of EF-Tumt rotates with respect to domains II and III 
when GTP is bound in comparison to when GDP is bound, creating the conformation that is 
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Figure 1-7.  Schematic diagram for protein synthesis in mammalian mitochondria. The 
figure represents the four stages of protein synthesis: initiation is carried out by IF2mt 
and IF3mt; elongation by EF-Tumt, EF-Tsmt, and EF-G1mt; termination is facilitated by 
RF1amt; ribosome recycling requires RRFmt and EF-G2mt. A possible active role of IF3mt is 
also indicated as an alternative mechanism. Note that only P- and A-sites are shown, 
since cryo-EM studies suggest that there is no site structurally equivalent to the E-site 
in mammalian mitochondrial ribosomes (2).  Figure obtained with permission from (1). 
active in binding the aa-tRNA (33).  The binding of EF-Tumt:GTP to mitochondrial Phe-tRNA 
(76 nM) is not as tight as the interaction between E. coli EF-Tu and bacterial Phe-tRNA (~1 
nM) (34;35).     
Mitochondrial elongation factor Ts (EF-Tsmt) is a 30.7 kDa protein that consists of an 
N-terminal domain and a core domain with N- and C-terminal subdomains (31).  EF-Tumt and 
EF-Tsmt interact through an extensive contact surface that includes domains I and III of EF-
Tumt and all three domains of EF-Tsmt (31;36).  EF-Tumt associates with EF-Tsmt with a binding 
constant of 5.5 nM (35). 
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In contrast to prokaryotic EF-G, which functions in both translation elongation and 
termination, two forms of EF-G are present in mitochondrial systems. Recent work has 
provided convincing evidence that the factor designated EF-G1mt catalyzes translocation but 
is inactive in the ribosome recycling step (37).  EF-G2mt works with RRFmt to release the 
tRNA and mRNA and to dissociate the monosome into subunits.  In contrast to EF-G1mt, EF-
G2mt is not active in translocation.  Thus, EF-G2mt is not biologically equivalent to a 
traditional translocase, and recently Tsuboi et al. (37) proposed that this factor be renamed 
RRF2mt to reflect its role in ribosome recycling.  
Two forms of the EF-G (EF-G1 and EF-G2) are present in a variety of microorganisms, 
and both proteins show significant sequence homology to each other.  Recent studies 
suggest that the roles of EF-G2 in bacteria vary from one organism to another.  For example, 
Mycobacterium smegmatis EF-G2 shows no ribosome dependent GTPase activity and is 
unable to catalyze translocation or ribosome recycling (38), while EF-G2 from T. 
thermophilus retains GTPase activity and behaves similarly to EF-G1 (39).   
Possible roles of EF-G1mt and EF-G2mt have been investigated in yeast.  In this 
organism, mutations of EF-G1mt lead to impaired activity in mitochondrial protein synthesis 
in vivo, but mutations in EF-G2mt failed to show any clear phenotype (40). Defects in 
mitochondrial translation have been observed in human patients due to mutations in EF-
G1mt, and these defects are generally lethal shortly after birth. No human defects in EF-G2mt 
have yet been found (41). 
When the translation machinery encounters a stop codon, a release factor (RF1amt) 
induces the hydrolysis of the newly formed polypeptide from its tRNA (42).  Following the 
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action of the release factor, the 55S complex carrying the deacylated tRNA and mRNA is 
targeted by RRFmt and EF-G2mt (43).  How the tRNA and the mRNA dissociate from the 
ribosome is not clear. 
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CHAPTER 2 
 
EVIDENCE FOR AN ACTIVE ROLE OF IF3mt IN THE INITIATION OF TRANSLATION IN 
MAMMALIAN MITOCHONDRIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of the work reported in this chapter has been published (1;2) and reprinted 
with permission.
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INTRODUCTION 
  Mitochondria are involved in a number of human diseases.  In particular, 
dysfunctions in mitochondria and mutations in mitochondrial DNA have been linked to 
genetic diseases, Alzheimers disease, Parkinsons disease, and other age-related 
neurodegenerative diseases (3).  Before the relationship between mitochondria and disease 
states can be fully understood, a number of fundamental questions about mitochondrial 
processes, including mitochondrial gene expression, must be answered. 
The mammalian mitochondrial genome contains 16 kilobase pairs of DNA (4), 
encoding two ribosomal RNAs, 22 transfer RNAs, and 13 proteins.  Translation of the mRNAs 
encoded by mitochondrial DNA requires the presence of a protein biosynthetic system that 
is distinct from that of the cell cytoplasm.  Mitochondrial ribosomes are 55S particles that 
have about half the rRNA content and twice the protein content of bacterial ribosomes (5).  
Mitochondrial ribosomal subunits have sedimentation coefficients of 28S and 39S, while 
bacterial ribosomal subunits have sedimentation coefficients of 30S and 50S and form 70S 
monosomes. 
Following removal of the mitochondrial import signal, IF3mt is a 29 kDa protein  
composed of three regions that have homology to the bacterial factor: the N-terminal 
domain, the linker, and the C-terminal domain (Figure 2-1). The N-terminal homology 
domain is preceded by an extension of 30 amino acids, and the C-terminal domain is 
followed by an extension of 33 amino acids.  Most of the functions of E. coli IF3 and IF3mt 
tested in vitro have been localized to the C-terminal domain.   
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Figure 2-1. Domain organization of E. coli IF3 and IF3mt.  The N-terminal extension of 
IF3mt spans from residue 32-61, the N-terminal domain spans from residue 62-130, the 
linker spans from residue 131-157, the C-terminal domain spans from residue 158-245, 
and the C-terminal extension spans from residue 246-278.  In E. coli, the N-terminal 
domain spans from residue 1-68, the linker from 69-92, and the C-terminal domain 
from 93-180.   
As mentioned in Chapter 1, translation initiation factors have similarities in the 
bacterial and mitochondrial systems, but several key differences are apparent.  Although 
IF2mt seems to serve similar functions as its prokaryotic counterpart, it has a 37 amino acid 
insertion that is believed to function in place of IF1 in translation (6).  Like E. coli IF3, the 
majority of the functions of IF3mt have been localized to the C-terminal domain.  Functions 
of E. coli IF3 include:  inducing the dissociation of monosomes by preferentially binding to 
the small ribosomal subunit; promoting the formation of initiation complexes; proofreading 
formed initiation complexes and dissociating those with non-canonical start codons; and 
mediating the interactions between the codon and anticodon.  While IF3mt is known to 
promote initiation complex formation, the other functions above have not been 
demonstrated for IF3mt.  However, IF3mt is thought to contain an additional proofreading 
function which reduces fMet-tRNA binding in the absence of mRNA.  This function is 
thought to be localized to the C-terminal extension and linker (7;8). This observation 
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suggests that mRNA binding normally precedes fMet-tRNA binding in the mitochondrial 
system. 
Full length IF3mt is thought to bind on the interface side of the small subunit close to 
the platform with a Kd of 30 nM (8).  The binding constant was determined using both 
Surface Plasmon Resonance and Microcon centrifugation.  The isolated C-terminal domain 
of IF3mt also has a strong affinity for the 28S subunit and binds with a Kd of 95 nM (8).  The 
isolated N-terminal domain of E. coli IF3 has no detectable binding to the 30S ribosomal 
subunit (9).  This domain of IF3 is thought to increase the affinity of the intact IF3 protein 
for the 30S subunit by two orders of magnitude.  In contrast, the isolated N-terminal 
domain of IF3mt binds to the 28S subunit with a Kd of 390 nM (8).  The N- and C-terminal 
extensions of IF3mt are not required for binding of the protein to the small subunit, and 
removal of the extensions has almost no effect on the binding constant (10).  However, the 
C-terminal extension, along with the linker, plays a role in preventing fMet-tRNA binding to 
the 28S subunit in the absence of mRNA (8). 
Native IF3mt has never been detected or purified from mammalian mitochondria. 
This observation probably reflects the low abundance of IF3mt in mitochondria.  Further, 
detection of the cDNA for IF3mt in the EST databases is a challenge due to the relatively low 
sequence conservation of this factor (20-25 % identity to prokaryotic IF3) (11).  Hence, 
MitoProtII was used to predict the cleavage site for the removal of the mitochondrial import 
signal (12).  This program predicted an import signal of 31 amino acids, giving a 247 amino 
acid mature protein. This factor is predicted to have a molecular mass of 29 kDa after 
removal of the predicted mitochondrial import sequence.   
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MATERIALS AND METHODS 
Materials 
  Laboratory supplies and chemicals were purchased from Sigma-Aldrich or Fisher 
Scientific.  A rabbit polyclonal primary antibody to the region of IF3mt homologous to the 
bacterial factors was prepared as previously described (7).  Bovine mitochondrial ribosomes 
(55S), ribosomal subunits (28S and 39S), bovine IF2mt, and yeast [
35S]fMet-tRNA were 
prepared as described (2;13;14).  
 
Preparation of IF3mt 
 An EST encoding human IF3mt was obtained from American Type Culture Collection 
and the region encompassing the mature protein (amino acids 32 to 278) was previously 
cloned into pET-21c(+) using the NdeI and XhoI restriction sites (11).  This vector provides a 
C-terminal His6-tag.  This construct was transformed into E. coli BL21(DE3) carrying the 
pArgU218 plasmid to supply the isoacceptor of tRNAArg recognizing the AGA and AGG 
codons.  Twelve mutated derivatives of IF3mt, designated IF3mt:1-12 (Table 2-1), were 
prepared by site-directed mutagenesis using the primers listed in Table 2-2 and the 
QuikChange site-directed mutagenesis protocol (Stratagene).  All mutations were verified by 
DNA sequencing.  The mutated plasmids were transformed into E. coli BL21 RIL cells 
(Stratagene).   
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Mutation Location 
Residues 
Mutated 
Residues 
Changed to 
IF3mt:1 N-domain KKTKK (66-70) AATAA 
IF3mt:2 N-domain TSTE (121-124) AAAA 
IF3mt:3 Linker REMEK (143-147) AAMAA 
IF3mt:4 C-domain KKK (184-186) AAA 
IF3mt:5 C-domain HD (170-171) AA 
IF3mt:6 C-domain K (175) A 
IF3mt:7 C-domain K (194) A 
IF3mt:8 C-domain EE (207-208) AA 
IF3mt:9 C-extension EE (247-248) AA 
IF3mt:10 C-extension KE (252-253) AA 
IF3mt:11 C-extension DT (261-262) AA 
IF3mt:12 C-extension KD (265-266) AA 
 
 
  Table 2-1.  Summary of the mutations prepared in IF3mt. 
 
Cells were grown to an A595 of 0.6 in Lauria Broth (LB) media containing ampicillin 
(100 µg/mL) and chloramphenicol (34 µg/mL), at which time the expression of IF3mt was 
induced using 50 µM isopropyl β-D-1-thiogalactopyranoside (IPTG).  Cells were allowed to 
induce either overnight at 25 °C or for six h at 37 °C.  Similar yields were obtained from cells 
grown under either of these conditions.  After induction, cells were harvested by 
centrifugation at 5,000 rpm (7,300 g) for 30 min at 4 °C in a Sorvall RC3B centrifuge using 1 L 
swinging buckets in the H-6000A rotor. The cell pellets were resuspended in buffer 
containing 50 mM Tris-HCl (pH 7.8), 50 mM NH4Cl and 10 mM MgCl2 and collected again by 
centrifugation at 7,000 rpm (5,856 g) 
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for 30 min in an SS34 rotor.  The cell pellets were carefully drained and weighed.  At this 
point, the cells could be stored at -70 °C after being fast-frozen in a dry ice isopropanol 
bath. The yield of cells was generally around 5 g/L of media.  Cells were resuspended in ice 
cold lysis buffer (10 mL buffer per g of cell pellet) containing 50 mM HEPES-KOH (pH 7.8), 7 
mM MgCl2, 10 % glycerol, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 100 mM KCl, 6 
IF3mt: Forward Primer 
1a GACAAAAGCGAATAAAACAGCTTTTAGTAACG 
1b AGACAGCAGCGAATAAAACAGCTTTTAGTAACG 
1c CACCCAGAATGAAGGAGCAAAGACAGCAGCG 
1d GAATGAAGGAGCAGCGACAGCAGCG 
2 GGTTCAAAGGAACGCCGCCGCAGCACCTGCAGAGTAT 
3a CAGAGGCTGGCTGCGATGGAGAAGGCGAACCC 
3b GCTGCGATGGCTGCGGCGAACCC 
4 GCAGTGGATTGCGGCAGCACACCTAGTCC 
5 TCTTCAAATATTGGACAAGCTGCTTTGGACACAAAGACTAAACAG 
6 GATTTGGACACAGCGACTAAACAGATTCAG 
7 CCAGATTACCATAGCGAAAGGAAAAAATGTAGACG 
8 GTCAGAAAATGAAATGGCGGCGATATTTCATC 
9 GCTTTGAGCAAAAATGCGGCGAAGGCATATAAAG 
10 GGAGAAGGCATATGCAGCAGAAACTCAAGAGACCC 
11 GACCCAGGAAAGAGCCGCTTTGAACAAAGACC 
12 GAGACACTTTGAACGCAGCCCATGGAAATGATAAGG 
 
 
 
Table 2-2. Primers used in preparation of IF3mt constructs.  Mutated nucleotides are 
highlighted in gray.  The reverse primers used were the inverse complements of the 
forward primers in each case.  To make the four amino acid mutations in IF3mt:1, four 
sequential mutations were required using primers 1a-1d sequentially.  To make the four 
amino acid mutations in IF3mt:3, two sequential mutagenic reactions were carried out 
using primers 3a and 3b as indicated. 
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mM β-mercaptoethanol (BME), 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 0.8 % 
Triton X-100 and sonicated for seven pulses (10 s on, 50 s off).  Solid NH4Cl was added to a 
final concentration of 0.5 M over a period of 15 min while stirring on ice.  Cell debris was 
removed by centrifugation at 15,000 rpm (27,000 g) for 30 min in a Sorvall SS34 rotor at 4 
°C. The supernatant was retained.  Ni-NTA agarose was equilibrated in Ni-NTA wash buffer 
containing 50 mM Tris-HCl (pH 7.8), 7 mM MgCl2, 10 % glycerol, 1M KCl, 10 mM imidazole, 7 
mM BME, and a 50 % slurry in this buffer was prepared.  This slurry (1 mL/2 L cell culture) 
was added to the cell lysate and the sample was mixed for 30 min at 4 °C using a test tube 
rocker. This mixture was then sequentially transferred to a (5 mL) polypropylene column 
(Qiagen).  The column was washed with 100 mL of Ni-NTA wash buffer, after which the 
protein was eluted with six sequential 1 mL aliquots of Ni-NTA elution buffer containing 50 
mM Tris-HCl (pH 7.8), 7 mM MgCl2, 10 % glycerol, 40 mM KCl, 150 mM imidazole, 7 mM 
BME.  Each aliquot of Ni-NTA elution buffer was allowed to sit on the column for 5 min 
before being collected.  All fractions were combined and dialyzed against one hundred 
volumes of ice cold dialysis buffer (Buffer I) containing 20 mM HEPES-KOH (pH 7.6), 10 mM 
MgCl2, 50 mM KCl, 10 % glycerol, and 6 mM BME for 2 h, with a change of Buffer I after 1 h. 
 
Purification of IF3mt by High Performance Liquid Chromatography (HPLC) 
The IF3mt preparation has one major contaminant following the Ni-NTA step.  The 
contaminant is a 19 kDa C-terminal fragment of IF3mt (11). This contaminant often 
represents 30-40 % of the total protein in the sample.  Due to the presence of this 
contaminant, a second step of purification was carried out using HPLC or gravity 
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chromatography. For the HPLC method, the partially purified IF3mt (~3 mg in ~5 mL) 
prepared from 2 L of cell culture was dialyzed against a 100-fold excess of Buffer I for 1 h. 
The dialyzed sample was filtered through a 0.45 μm filter and applied at a flow rate of 0.6 
mL/min to a TSKgel SP-5PW column (7.5 cm x 7.5 mm, TosoHaas Inc., Japan) that was 
equilibrated in Buffer I containing 150 mM KCl. The column was washed until the 
absorbance at 280 nm returned to baseline and was then developed with a linear gradient 
(40 mL) from 0.15 M to 0.55 M KCl in Buffer I at a flow rate 0.5 mL/min. Fractions (0.5 mL) 
were collected using a Shimadzo fraction collector into Eppendorf tubes from which the lids 
had been removed and that were balanced in 100 x 13 mm glass test tubes. Fractions 
containing full-length IF3mt were identified by electrophoresis on 15 % SDS-polyacrylamide 
gels. These fractions were pooled, fast-frozen in a dry ice isopropanol bath and stored at -70 
°C. 
 
Purification of IF3mt by Gravity S-Sepharose Column 
Since HPLC equipment is not standard in all laboratories, we also developed a gravity 
chromatographic method for the purification of IF3mt.  In this procedure, the dialyzed 
sample (~5 mL, ~3 mg from 2 L cell culture) from the Ni-NTA column was applied to an 
S-Sepharose column (8 mL, 6.5 cm x 1.75 cm) equilibrated in Buffer I containing 250 mM 
KCl.  The column was developed with a linear gradient (40 mL) from 250 mM to 550 mM KCl 
in Buffer I. Fractions (0.75 mL) were collected at a flow rate of 1 mL/min while the 
absorbance at 280 nm was monitored using an Isco UA-6 UV-Visible detector at an 
absorbance scale setting of 0.5 and a 5 mm optical flow cell.  Fractions containing the 29 
   
31 
 
kDa mature form of the tagged IF3mt were identified by SDS-polyacrylamide gel 
electrophoresis.  The S-Sepharose column could be reused. Before reuse, it was washed 
with ten volumes of Buffer I  containing 550 mM KCl, followed by ten volumes of Buffer I 
containing 1M KCl.  It was then equilibrated in Buffer I containing 250 mM KCl.  The column 
was allowed to sit overnight in this buffer and then washed again briefly with Buffer I 
containing 250 mM KCl before use.  
The IF3mt eluted from the S-Sepharose column described above still contained small 
amounts of the 19 kDa fragment and other minor contaminants.  Fractions containing the 
29 kDa band were combined, diluted 1.5-fold with Buffer I and dialyzed against 100 volumes 
of ice cold Buffer I  at 4 °C for two h with a change of buffer after one h.  The dialysate was 
applied to the S-Sepharose column again. The column was developed with a 40 mL linear 
gradient from 250 to 550 mM KCl in Buffer I and the absorbance at 280 nm was monitored 
as described above. Aliquots of various fractions were analyzed by SDS-polyacrylamide gel 
electrophoresis on 15 % gels for the presence of IF3mt. The second run through the S-
Sepharose column eliminated the 19 kDa fragment and had a negligible effect on activity.  
Fractions containing full-length IF3mt were then combined, dialyzed against 100 volumes of 
ice cold Buffer I at 4 °C for two h with a change of buffer after one h, and then stored at -70 
°C until further use. 
 
Assay of IF3mt on E. coli Ribosomes 
The standard assay (0.1 mL) contained 50 mM Tris-HCl (pH 7.8), 60-80 mM KCl, 5 
mM MgCl2, 0.25mM GTP, 1 mM phospho(enol)pyruvate (PEP), 0.9 unit pyruvate kinase, 1 
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mM dithiothreitol (DTT), 12.5 µg poly(A,U,G), 0.055 µM (5.5 pmol) [35S]fMet-tRNA 
(60,000-70,000 cpm/pmol), 0.4 µM E. coli 70S ribosomes, a saturating amount (0.1 µM, 10 
pmol) of IF2mt, and the desired amount of IF3mt generally ranging from 0 to 0.1 µM (0 to 10 
pmol).  Samples were incubated at 37 °C for 15 min.  After incubation, each sample was 
rapidly diluted with 3-4 mL of cold Mg5 Wash Buffer containing 50 mM Tris-HCl (pH 7.8), 80 
mM KCl, and 5 mM MgCl2, and filtered through a nitrocellulose membrane that was wetted 
with cold Mg5 Wash Buffer.  Filtration was facilitated by use of a gentle vacuum provided by 
a pump. The filters were washed with 3 aliquots (3-4 mL each) of cold Mg5 Wash Buffer 
with the vacuum on.  Background binding (generally 0.2-0.5 pmol) obtained in the absence 
of IF3mt was subtracted from each value.  One unit is defined as the binding of 1 pmol of 
[35S]fMet-tRNA to ribosomes under the assay conditions described above.  The specific 
activity of the purified protein was about 1,700 units/mg when tested on 70S ribosomes. 
The total yield of purified protein was about 2 mg from 2 L cell culture.  
 
Assay of IF3mt on Bovine Mitochondrial Ribosomes 
Reaction mixtures (0.1 mL) contained 50 mM Tris-HCl (pH 7.6),  0.1 mM spermine, 
35 mM KCl, 4.5 mM MgCl2, 0.25 mM GTP, 1 mM DTT, 1 mM PEP, 0.9 unit pyruvate kinase, 
12.5 µg poly(A,U,G), 0.42 µM IF2mt, 0.06 µM [
35S]fMet-tRNA, 0.04-0.06 µM (about 4-6 pmol) 
mitochondrial 55S tight couples (1 A260 unit is 32 pmol of 55S ribosomes), 0.04 µM 
[35S]fMet-tRNA, a saturating amount of IF2mt (about 0.1 µM, 10 pmol) and the desired 
amount of IF3mt (generally 0.005 to 0.1 µM). These initiation complex formation assays 
were incubated at 37 °C for 15 min and processed as described above using Mg5 Wash 
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Buffer in which the concentration of KCl was reduced to 40 mM. All of the values reported 
were corrected for the amount of radioactivity retained on the filters in the absence of IF3mt 
(about 0.1 pmol). 
 
Preparation of Mutated Derivatives of IF3mt 
The IF3mt derivatives were purified using the methodology listed above for the 
purification of wild-type IF3mt (IF3mt:WT).  For use in assays, the derivatives were dialyzed in 
Buffer 1 for 2 h with a change of buffer after 1 h.  Alternatively, the mutated derivatives 
were dialyzed in 50 mM phosphate buffer (pH 7.6) for 4 h with a change of buffer after 2 h.  
The mutated derivatives in phosphate buffer were tested for structural integrity by 
comparing the α-helical content present determined by circular dichroism (CD) to that of 
IF3mt:WT using an Aviv Model 62DS CD Spectrometer.  IF3mt:1 was excluded from CD 
measurements due to the fact that it failed to separate from its truncated 19 kDa fragment 
during HPLC purification. 
 
Preparation of Polynucleotide Phosphorylase 
Initiation complex assays were carried out using poly(A,U,G) as the mRNA.  Since this 
polymer is no longer commercially available, it was prepared using polynucleotide 
phosphorylase.  The gene encoding E. coli polynucleotide phosphorylase was previously 
cloned into the pET11a plasmid in E. coli BL21 (DE3) pLysS cells and was a generous gift 
from Dr. George H. Jones (Dept. of Biology, Emory University, Atlanta, GA) (15).  The 
enzyme was purified as described (15).  To follow the enzyme during purification, activity 
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assays were carried out.  Reaction mixtures (100 µL) contained 50 mM Tris-HCl (pH 8.0), 5 
mM MgCl2, 5 mM [
3H]ADP (7 cpm/pmol), and 20 µL of appropriate fractions.  The reactions 
were incubated at 37 °C for 20 min, at which point 500 µg bovine serum albumin (BSA) was 
added, and the reactions were precipitated with cold 5% trichloroacetic acid (TCA) (16).  The 
precipitate was collected by filtration using impure nitrocellulose filters (Millipore).  The 
amount of polymerized [3H]ADP was quantitated using a scintillation counter.  Following 
final purification of the enzyme, fractions with ADP polymerization activity were pooled and 
dialyzed against 50 % ammonium sulfate overnight without stirring at 4 °C.  The enzyme was 
stored in 1 mL aliquots at -20 °C. 
 
Synthesis and Purification of Poly(A,U,G) 
A 10 mL reaction containing 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 5 mM ADP, pH 
7.0, 5 mM UDP, pH 7.0, 5 mM GDP, pH 7.0, and 1 mg polynucleotide phosphorylase was 
incubated at 37 °C overnight.  Following synthesis, the reaction mixture was extracted using 
phenol (pH 8.0)/chloroform, and the RNA was precipitated with ethanol overnight at -20 °C.  
RNA was collected by centrifugation at 15,000 rpm in the Sorvall SS-34 rotor for 30 min.  
The pellets were resuspended in 5 mL sterile H2O and applied to a Sephadex G-50 column 
(74 cm x 1.1 cm) equilibrated in 3 mM EDTA, pH 8.0, and 25 mM Tris-HCl (pH 7.8).  The 
column was developed with 150 mL of the same buffer, and 1 mL fractions were collected 
at a flow rate of 1 mL/min. UV absorbance was monitored at 260 nm.  Fractions containing 
poly(A,U,G) were pooled and precipitated using 2.5 volumes 100% ethanol overnight at -20 
°C.  The poly(A,U,G) was collected by centrifugation at 15,000 rpm for 30 min in the SS-34 
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rotor and stored at -20 °C.  Before use, the pellets were dissolved in sterile H2O to a final 
concentration of 13 µg/µL. 
 
Quantitation of the Binding of IF3mt and Its Derivatives to Mitochondrial 28S Subunits Using 
Microcon Centrifugation 
Ribosome binding reactions were carried out as described (10) in Binding Buffer (100 
µL) which contained 10 mM Tris-HCl (pH 7.6), 40 mM KCl, 7.5 mM MgCl2, 1 mM DTT, and 
0.1 mM spermine.  Reactions also contained 50 nM 28S subunits (5 pmol) and IF3mt (0.15-1 
pmol, 1.5-10 nM) or its derivatives. The reactions were incubated for at 25°C for 20 min, at 
which time the reaction mixtures were added to the Microcon spin columns (Millipore) and 
centrifuged at 12,000 rpm (10,900 g) for 2 min. Binding Buffer (100 µL) was used to wash 
the Microcon columns, using centrifugation as described above to collect the Binding 
Buffer. To recover the IF3mt bound to 28S subunits (retained on the filter), 100 μl Binding 
Buffer was added to the column, the column was inverted, and then centrifuged for 1 min 
as described above.  IF3mt was released from the ribosome by the addition of EDTA to a final 
concentration of 20 mM.  The sample containing the bound IF3mt was applied to a dot blot 
apparatus (Bio-Rad).  The amount of IF3mt bound to 28S subunits was determined 
colorimetrically using a dot blot probed with antibodies against IF3mt as described 
previously (10).  A control curve for analysis of the dot blot was prepared by spotting 
various concentrations of IF3mt (0.5-1.2 pmol, 5-12 nM), 28S (5 pmol, 50 nM), and EDTA (20 
mM) directly onto the dot blot nitrocellulose membrane to quantify the change in color 
versus the amount of protein.  A blank value corresponding to the color change of the 
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membrane in the absence of IF3mt was subtracted from each value.  The calibration curve 
was linear over this range.  The Image Quant software program was used to calculate the 
number of pixels on the dot blot membrane.   
 
Dissociation of Mitochondrial 55S Ribosomes by IF3mt and its Mutated Derivatives 
Mitochondrial 55S ribosomes (8 pmol, 0.08 µM) were incubated in a buffer (100 µL) 
containing 50 mM Tris-HCl (pH 7.6), 5 mM MgCl2, 40 mM KCl, and 1 mM DTT in the absence 
or presence of 80 pmol (0.8 µM) IF3mt or its mutated derivatives at 37 °C for 15 min.  The 
samples were placed on ice for 10 min and then loaded onto 10-30 % sucrose gradients 
prepared in the buffer above and analyzed as previously described by monitoring the A254 
during fractionation of the gradients (10).  Each 55S ribosome sample contained some free 
39S subunits.  Therefore, the percentage of 55S particles was determined by comparing the 
area of the 55S peak on the absorbance profile to the total area of the 28S, 39S, and 55S 
peaks combined to account for this contamination.  Areas under the peaks were 
determined using the width of the peak at ½ the maximal height multiplied by the height.  
To determine the percentage dissociation, the amount of 55S particles in the absence of 
IF3mt was set to 100% and compared to the amount of 55S particles observed in the 
presence of IF3mt. 
 
Inhibition of fMet-tRNA Binding to 28S Subunits by IF3mt in the Absence of mRNA 
The inhibition of [35S]fMet-tRNA binding to 28S subunits in the absence of mRNA 
was tested as described (7).  Small subunits (6.2 pmol, 0.062 µM) were incubated under the 
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Figure 2-2. Model of IF3mt.  The N-terminal homology domain of IF3mt is shown in red, 
the linker is shown in green, and the C-terminal homology domain is shown in blue. 
assay conditions described for mitochondrial ribosomes above with saturating amounts of 
IF2mt (25 pmol, 0.25 µM) and [
35S]fMet-tRNA (5 pmol, 0.05 µM) in the presence or absence 
of IF3mt (0-12 pmol, 0-0.12 µM) or its mutated derivatives for 15 min at 25 °C in 100 µL 
reaction mixtures.  The amount of [35S]fMet-tRNA remaining bound to the subunits was 
determined using a nitrocellulose filter binding assay (17). 
 
RESULTS 
Design of IF3 Mutations 
A model of the region of IF3mt homologous to the bacterial factor was developed 
using the modeling program Insight II (Figure 2-2).  The N-terminal homology domain was 
modeled after the crystal structure of the Bacillus stearothermophilus IF3 (PDB coordinates 
1TIF (18)). This region of IF3 folds into a mixed 4-stranded β-sheet packed against a single 
helical unit (Helix 1) lying across the sheet and a second -helix (Helix 2) extending into the 
linker region.  The model of the N-terminal homology domain of IF3mt is quite similar to that 
of the crystal structure of the B. stearothermophilus factor despite the low percent identity 
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(<23 %) between these domains.  The C-terminal homology domain was modeled after the 
NMR structure of the mouse IF3mt (PDB coordinates 2CRQ, to be published) which has been 
shown to consist of two -helices (H3 and H4) lying on top of a 4-stranded β-sheet. The 
sequence of the C-terminal homology domain of the human factor is 72 % identical to that 
of mouse IF3mt. The predicted structure of this domain of human IF3mt is quite similar to 
that of the mouse factor, except that one of the β-strands is modeled in two sections due to 
the presence of an internal proline residue.  In the model, the linker region is depicted as 
being partially α-helical.  However, biochemical studies of the linker regions of IF3 from 
several sources suggest that this region has considerable flexibility (8;19-21).  The model 
does not include the N- and C-terminal extensions, which were predicted to be disordered.   
Mitochondrial 55S ribosomes are composed of approximately 2/3 protein and 1/3 
RNA.  The interface between the 28S and 39S subunits is rich in RNA (5).  Significant 
electrostatic interactions between IF3mt (pI ~10) and the 12S small subunit rRNA are 
expected to play an important role in the function of this factor.  To identify residues in 
IF3mt potentially involved in binding to the small subunit or in other functions of this factor, 
clusters of charged amino acids predicted to be exposed on the surface in the model of 
IF3mt (Figure 2-3) were changed to alanine (Figure 2-4).  Twelve different mutated 
derivatives (IF3mt:1-12) were made in the N- and C-terminal domains, the linker, and the C-
terminal extension.  The charges of these residues are generally conserved among 
vertebrate IF3mt, and partially conserved with the mosquito, fruit fly, and bacterial factors 
(Figure 2-4).  No mutations were made in the N-terminal extension, because this region is 
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Figure 2-3.  Model of IF3mt showing IF3mt:1-8.  The N-terminal domain is shown in red, 
the linker is in green, and the mutated residues are in blue.  IF3mt:1 could not be 
modeled based on the crystal structure of B. stearothermophilus because these 
residues are not present in this IF3 nor are they present in the NMR structure of the 
N-domain of E. coli IF3 (2;3).  IF3mt:1 has been placed in the model at the N-terminus 
of the protein for illustrative purposes.  The C-terminal homology domain is shown in 
blue and the mutated residues are shown in orange. 
 
 
IF3mt:       1       2        3    4      5    6    7     8 
Human IF3mt  KKIKK    TSTE    REMEK    KKK    HD    K    K    EE 
Bovine IF3mt  TKKKK    ASAE    REAER    EKK    HD    K    K    EE 
Mouse IF3mt  -RKQK    TSSE    REQEK    EKK    HD    K    K    EE 
Mosquito IF3  -ATAE    LKTQ    REEKK    NKQ    HD    K    S    ES 
Fruitfly IF3  -RTRD    AKTG    -QSRS    GKR    HD    R    Q    ER 
B. stearo IF3  -----    PNAK    EKEAR    EKG    HD    K    R    QR 
 
 
IF3mt:   9 10 11 12 
Human IF3mt  EE KE DT KD   
Mouse IF3mt  EE RE DT KD  
Bovine IF3mt  EE KA DA GG 
 
Figure 2-4.  Conservation of the charged residues mutated in IF3mt:1-12.  Positively 
charged residues are shown in dark gray and negatively charged residues are shown in 
light gray.  The numbers above each cluster of residues indicate the IF3mt derivative 
containing mutations of those residues.  B. stearothermophilus IF3 does not have 
residues corresponding to IF3mt:1. These residues are present in E. coli IF3 as KRVQT.  
 
poorly conserved and no known function has been attributed to the N-terminal extension 
alone.   
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The N-terminal domain of E. coli IF3 does not bind independently to 30S subunits 
(9).  In contrast, the N-terminal domain of IF3mt binds 28S subunits with a Kd of 390 ± 60 nM 
(8).  Two clusters of residues in the N-terminal domain were mutated (Figure 2-3).  The 
selected residues were fairly well conserved among the mammalian factors (Figure 2-4) but 
less conserved with the IF3mt of other organisms.  IF3mt:1 is located five residues into the N-
terminal domain of IF3mt in a region where no structural information is available.  Its 
predicted location is shown in the model (Figure 2-3).  This region was selected for 
mutagenesis since the first six residues of E. coli IF3 are important for the function of this 
factor (22).  IF3mt:2 is also located in the N-terminal domain in a loop between two β-
strands facing away from the linker region.  IF3mt:3 is located in a predicted α-helical region 
in the IF3mt linker.  IF3mt:4-6 are located in the C-terminal domain of IF3mt in an α-helix (Helix 
3) predicted previously to be essential for the function of the E. coli protein (23).  IF3mt:7 is 
also in the C-terminal domain at the tip of a β-strand (corresponding to β-strand 7 in the 
prokaryotic factors) in the center of the domain.  IF3mt:8 is located behind IF3mt:7 on the 
opposite face of the C-terminal domain (Figure 2-3).  IF3mt:9-12 are located in the C-
terminal extension of IF3mt, where no structural data is currently available.  A summary of 
the IF3mt mutations is shown in Table 2-1.   
Purification of IF3mt by Ni-NTA chromatography did not eliminate the 19 kDa 
contaminant.  Thus, subsequent purification by HPLC chromatography was necessary.  HPLC 
purification resulted in a column elution profile characterized by two distinct peaks (Figure 
2-5A).  The two peaks correspond to the 19 kDa fragment, which elutes from the column 
first, followed by the 29 kDa full-length protein.  Polyacrylamide gel electrophoresis of 
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Figure 2-6.  Circular dichroism spectrum of IF3mt:WT. 
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Figure 2-5.  Purification of IF3mt.  A.  HPLC elution profile of IF3mt.  B.  
SDS-PAGE gel showing migration of IF3mt and its truncated 
contaminant. 
fractions eluted 
from the HPLC 
column show the 
separated 19 kDa 
(fractions 30-34) 
and 29 kDa 
(fractions 35-40) 
forms of IF3mt 
(Figure 2-5B).  
Purification of 
mutated variants of IF3mt resulted in the same approximate ratio of 19 kDa contaminant to 
the 29 kDa full-length protein as is shown in Figure 2-5B. 
The mutated proteins were purified and tested for structural integrity by measuring 
the α-helical content using CD.  The CD spectrum of IF3mt:WT is shown in Figure 2-6.  
IF3mt:WT was 
determined to 
have 21 ± 3% α-
helical content 
using the CD Pro 
analysis software.  
This agrees with 
the model if the 
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Figure 2-7.  Effect of IF3mt:WT, IF3mt:7,  and IF3mt:5 on 
initiation complex formation using mitochondrial 55S 
ribosomes.  [35S]fMet-tRNA binding to mitochondrial 55S 
particles was tested in the presence of saturating amounts 
of IF2mt using IF3mt:WT (closed circles), IF3mt:7 (closed 
squares),  or IF3mt:5 (closed diamonds). A blank 
representing the amount of [35S]fMet-tRNA bound to 
ribosomes in the absence of IF3mt (~0.1 pmol) was 
subtracted from each value.   
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linker region is considered to be flexible instead of a rigid α-helix.  All mutated proteins had 
CD profiles similar to that of IF3mt:WT, and analysis of the α-helical content showed that all 
mutated proteins contained the same helical content as IF3mt:WT within error.  IF3mt:1 was 
excluded from CD measurements because it failed to separate from its truncated fragment 
using HPLC purification. 
 
Mutations in the N-terminal Domain and Linker 
 IF3mt derivatives with mutations in the N-terminal domain and linker were tested 
for their abilities to 
promote [35S]fMet-tRNA 
binding to both E. coli 
and mitochondrial 
ribosomes in the 
presence of IF2mt.  This 
assay primarily measures 
the ribosomal subunit 
dissociation activity of 
this factor (11).  A 
representative graph 
showing initiation 
complex formation as a function of increasing amounts IF3mt is shown in Figure 2-7.  IF3mt:1 
and IF3mt:2 showed activity similar to the unmutated factor (IF3mt:WT) on both E. coli and 
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Figure 2-8.  Summary of the activities of IF3mt:1-12 in initiation 
complex formation.  This assay primarily measures ribosome 
dissociation.  The activity of IF3mt:WT was set to 100 % and the 
mutated derivatives were compared to that value using the linear 
regions of the dose response curves.  The activity on 70S 
ribosomes is shown in black, while activity on mitochondrial 
ribosomes is in striped gray.  Derivatives identical to wild-type 
IF3mt within error are shown as 100 %. 
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mitochondrial ribosomes (Figure 2-8), indicating that these residues are not important for 
the activity of this protein.  IF3mt:3, located in the linker region of the protein, showed a 
slight reduction in 
activity in initiation 
complex formation 
on both E. coli and 
mitochondrial 
ribosomes (Figure 
2-8).  The slight loss 
of activity for 
IF3mt:3 was further 
explored in an 
assay that 
measures the 
ability of the 
protein to dissociate mitochondrial 55S ribosomes using sucrose density gradient 
centrifugation (Figure 2-9).  IF3mt:3 showed the same subunit dissociation pattern as 
IF3mt:WT in this assay, which indicates that it did not have any significant defect in this 
function (Figure 2-10). 
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        A     B     C 
 
Figure 2-9.  Effect of IF3mt and its mutated derivates on the dissociation of 
mitochondrial 55S ribosomes.  Fractionation profiles of mitochondrial 55S ribosomes 
after centrifugation on a 10-30 % sucrose gradient.  Mitochondrial 55S ribosomes (8 
pmol) were incubated as described in Materials and Methods in the absence (A) or 
presence of 80 pmol IF3mt (B) or its mutated derivative IF3mt:6 (C) and subsequently 
subjected to centrifugation on a 10-30 % sucrose density gradient.  Gradients were 
fractionated while monitoring the A254.  
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Mutations in the C-terminal Domain 
  The C-terminal domain of IF3mt with the linker binds to the small ribosomal subunit 
with nearly the same affinity as the full-length protein and shows the same activity as the 
full length protein in stimulating fMet-tRNA binding to mitochondrial ribosomes (8).  IF3mt 
derivatives with mutations in the C-terminal domain were tested for activity in initiation 
complex formation on E. coli and mitochondrial ribosomes.  IF3mt:7 and IF3mt:8 had the 
same activity as the wild-type protein (IF3mt:7 Figure 2-7, IF3mt:8 Figure 2-8).  IF3mt:4 
showed slightly reduced activity, but still maintained its ability to dissociate 55S ribosomes 
as nearly as well as the wild-type protein (Figure 2-10).  Its slight deficiency in ribosome 
dissociation agrees with the slight deficiency in initiation complex formation (Figure 2-8).  
However, IF3mt:5 and IF3mt:6 had almost no activity in promoting initiation complex 
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Figure 2-10.  Percentage of mitochondrial 55S ribosomes remaining after 
the addition of IF3mt:WT or its mutated derivatives as measured by sucrose 
density gradient centrifugation. 
formation on E. coli ribosomes, and had significantly reduced activity on mitochondrial 
ribosomes (IF3mt:5 Figure 2-7, IF3mt:6 Figure 2-8).    
Since neither IF3mt:5 nor IF3mt:6 were active in stimulating initiation complex 
formation, an assay that basically measures ribosome dissociation, their abilities to promote 
the dissociation of 55S ribosomes was examined directly by sucrose density centrifugation.  
Both proteins were deficient in dissociation activity (IF3mt:6, Figure 2-9; IF3mt:5 Figure 2-10).  
IF3mt:5 dissociated 55S ribosomes by only ~15 %, compared to just over 50 % dissociation 
with the same level of IF3mt:WT (Figure 2-10).  IF3mt:6 had essentially no activity in the 
ribosome dissociation assay.   
One possible explanation for the lack of activity observed with IF3mt:5 and IF3mt:6 is 
that these mutated proteins are unable to bind 28S subunits, and, therefore, are unable to 
effectively prevent the interaction of the 28S and 39S ribosomal subunits.  To test this 
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Figure 2-11.  Binding assays performed using Microcon spin 
columns as described (2;2;6).  Inset: Calibration curve of IF3mt: 
WT using a colorimetric assay and a dot blot apparatus.   This 
curve was used to determine the amount of IF3mt bound to 
mitochondrial 28S ribosomes in the Microcon centrifugation 
assay as described in Materials and Methods. 
 
IF3mt Kd (nM) 
IF3mt:WT 35 ± 13 
IF3mt:5 19 ± 11 
IF3mt:6 45 ± 17 
 
Table 3.  Binding of IF3mt and its mutated derivatives to 28S 
mitochondrial ribosomes.  Kd values of IF3mt:WT and its mutated 
derivatives binding to 28S mitochondrial ribosomes as determined by 
Microcon centrifugation. 
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Table 2-3.  Binding constants of IF3mt and its mutated derivatives 
to 28S mitochondrial subunits.  Kd values of IF3mt:WT and its 
mutated derivatives binding to 28S mitochondrial subunits as 
determined by Microcon centrifugation. 
possible explanation directly, the binding of IF3mt and its mutated derivatives to 28S 
subunits was 
measured using 
Microcon-100 
centrifugation 
followed by 
immunological 
detection of IF3mt on 
a dot blot apparatus 
(10).  This method 
takes advantage of 
the observation that, 
in the absence of 28S 
subunits, IF3mt passes 
through the 
membrane while 
IF3mt bound to 28S 
subunits does not.  
The binding curve for 
IF3mt:6 is shown in 
Figure 2-11.  
IF3mt:WT binds to 28S subunits with a Kd of 35 ± 13 nM (Table 2-3).  As indicated in Table 2-
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Figure 2-12.  IF3mt-mediated inhibition of [
35S]fMet-tRNA 
binding to mitochondrial 28S subunits in the absence of mRNA.  
Mitochondrial 28S subunits were incubated with saturating 
amounts of IF2mt and [
35S]fMet-tRNA in the presence or absence 
of IF3mt:WT or its C-terminal extension mutated derivative 
IF3mt:9 as described (2;4).  The amount of [
35S]fMet-tRNA 
remaining bound to the filter in the presence of IF3mt:WT 
(closed squares) or IF3mt:9 (closed circles) was determined using 
a nitrocellulose filter binding assay. 
3, IF3mt:6 binds 28S subunits with a Kd of 45 ± 17 nM and IF3mt:5 binds to 28S subunits with 
a Kd of 19 ± 11 nM.  Since both mutated proteins show the same binding to 28S subunits as 
IF3mt:WT, the lack of activity of the mutated proteins in initiation complex formation and in 
the dissociation of 55S ribosomes into the 28S and 39S subunits cannot be attributed to a 
defect in their abilities to bind the SSU.  
 
Mutations in the C-terminal Extension 
  One unusual property of IF3mt is that its C-terminal extension is thought to play an 
important role in 
decreasing the 
amount of fMet-
tRNA bound to 
mitochondrial 28S 
subunits in the 
absence of mRNA.  
This observation 
suggests that mRNA 
binding should 
precede fMet-tRNA 
binding in the 
mitochondrial system 
(7).  No structural 
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data is currently available for the C-terminal extension of IF3mt.  Modeling of this region 
indicated that it is probably disordered in solution.  Regions of highly charged amino acids 
(acidic and basic) conserved in vertebrate IF3mt lineages were selected for mutation to 
alanine residues (Figure 2-4).  All of these derivatives were as active as IF3mt:WT in 
promoting initiation complex formation on both E. coli and mitochondrial ribosomes (Figure 
2-8).  As indicated in Figure 2-12, IF3mt:WT inhibits the binding of fMet-tRNA to 28S subunits 
in the absence of mRNA.  IF3mt:5 and IF3mt:6 in the C-terminal domain, along with IF3mt:10, 
IF3mt:11, and IF3mt:12 in the C-terminal extension showed normal activity in this assay (data 
not shown).  However, IF3mt:9, also in the C-terminal extension, was unable to reduce the 
amount of fMet-tRNA bound to ribosomes in the absence of mRNA (Figure 2-12).  This 
observation pinpoints a region of the C-terminal extension that is critical for inhibiting 
initiation complex formation before the mRNA is bound.  Interestingly, the linker region of 
IF3mt also appears to have a role in preventing fMet-tRNA binding in the absence of mRNA 
(8).   
The C-terminal extension is predicted to emerge from the C-terminal domain near 
the linker region according to the model (Figure 2-3).  The linker, and, thus, the C-terminal 
extension, may span the region between the platform, where the C-terminal domain is 
thought to bind, and the head of the small subunit.  The linker may be positioned toward 
the mRNA binding channel as predicted in the model of McCutcheon et al. (24).  A transient 
association between of these regions of IF3mt with the mRNA channel near the P-site may 
permit this factor to distinguish prematurely formed initiation complexes.   
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   A      B 
 
Figure 2-13.  A.  Mutated residues in the C-terminal domain of E. coli IF3 and their 
effects on activity in initiation complex formation on E. coli ribosomes.  The activity 
remaining was based on the dissociation of 70S ribosomes, one of several assays 
carried out with these mutated derivatives of E. coli IF3.  The most drastic effects on 
activity are seen with the mutation in the center of the α-helix (Helix 4) on the back of 
the protein.  B.  Mutated residues in the C-terminal domain of IF3mt and the effects of 
these mutations on activity in initiation complex formation on mitochondrial 
ribosomes.  The most drastic effects are seen with the two mutations located at the 
base of Helix 3. 
>90% activity
≥70% activity
≤20% activity
N
IF3mt:5
IF3mt:6
IF3mt:4
IF3mt:8
IF3mt:7
N
DISCUSSION 
Comparison of Mutational Effects in IF3mt and E. coli IF3 
Both NMR (25) and mutational analysis (23;26) indicate that there are a number of 
contacts between E. coli IF3 and the SSU in the C-terminal domain.  These interactions 
appear to span much of Helix 3, the loop regions, and portions of Helix 4.  Key differences 
between IF3mt and the E. coli factor become apparent when the extensive battery of 
mutations made in Arg residues in E. coli IF3 are compared to those presented here in the 
mitochondrial factor (Figure 2-13).  In E. coli IF3, the most drastic effects on the activity of 
the factor in initiation complex formation measured by ribosomal subunit dissociation were 
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caused by a mutation in the center of Helix 4 in the C-terminal domain (Figure 2-13A) (23).  
This mutation also caused significant reductions in binding of the mutated protein to E. coli 
30S ribosomal subunits, suggesting that the defect in initiation arises from a weaker 
interaction with the SSU.  However, IF3mt:8, located in Helix 4 in the C-terminal domain of 
IF3mt, was able to stimulate initiation complex formation as well as the wild-type factor.  
This observation suggests that residues in Helix 4 may play a less important role in IF3mt 
than in E. coli IF3.  
In the mitochondrial factor, the most drastic effects were seen with two mutations 
in Helix 3 (IF3mt:5 and IF3mt:6, Figure 2-13B).  A mutation made in the center of this helix in 
E. coli IF3 (R112S) had only a modest effect on initiation complex formation (23), and the 
mutated derivative still retained >60 % of the activity observed with the wild-type factor.  In 
the mitochondrial factor, the mutations in Helix 3 are located closer to the base of the helix 
rather than in the center.  The side chains of these residues are predicted to be shifted 
approximately 90 degrees towards the front of the protein when compared to the side 
chains of the mutated residues in E. coli IF3.  IF3mt derivatives containing these mutations 
do not promote initiation complex formation, but are still able to bind to mitochondrial 28S 
subunits.  Thus, residues near the bottom of Helix 3 are not predicted to be in direct contact 
with the 28S subunits.  Rather, they may define a surface of IF3mt that contacts the 39S 
subunit during the dissociation of the 55S ribosomes into subunits. 
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Model for IF3mt-Mediated Dissociation of 55S Ribosomes 
Mutation of residues 170-171 and residue 175 in Helix 3 of the C-terminal domain of 
IF3mt drastically reduced the activity of IF3mt in promoting initiation complex formation.  
This assay basically measures the ability of IF3mt to dissociate 55S ribosomes.  Sucrose 
density gradient centrifugation confirmed the idea that these mutations inactivate IF3mt in 
ribosomal subunit dissociation.  The most logical explanation for these results is that the 
mutated proteins fail to bind mitochondrial 28S subunits and, therefore, cannot prevent 
39S joining.  However, both of these mutated derivatives of IF3mt bind to 28S subunits as 
well as the wild-type factor (Table 2-3).  This observation indicates that an alternative 
problem must underlie the loss of activity in these mutated IF3mt derivatives.  One possible 
explanation is that there are two distinct functionally important surfaces of IF3mt.  The first 
surface would function as a dissociation interface and may interact with one or both of the 
ribosomal subunits.  The second surface would function as a binding interface between the 
factor and the 28S subunit. 
Recent work has indicated that the position of the C-terminal domain of E. coli IF3 
blocks bridge B2b of the 70S ribosome, preventing the association of the large and small 
subunits when IF3 is present (27).  Bridge B2b involves 16S rRNA nucleotide 794 (28), which 
is in proximity to the proposed IF3 binding site on the 30S subunit (29;30).  Cryo-electron 
microscopy studies of mammalian mitochondrial ribosomes (5) indicates that this 
intersubunit bridge is one of several conserved contacts between the two subunits.  IF3mt is 
expected to bind to 28S subunits in a manner similar to the binding of E. coli IF3 to 30S 
subunits.  It is likely that residues 170-171 and 175 play an essential role in allowing IF3mt to 
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Figure 2-14.  Models for the mechanism of IF3mt in the dissociation of mitochondrial 
ribosomes.  A.  In the passive model, the subunits are in equilibrium with the 55S 
monosome (passive step 1).  IF3mt binds to free 28S subunits, preventing reassociation 
with the 39S subunit (passive step 2).  B.  In the active model, IF3mt interacts with the 
55S particle, forming a transient 28S:IF3mt:39S complex (active step 1), which then 
dissociates into a 28S:IF3mt complex and free 39S subunits (active step 2). 
block the formation of bridge B2b.  Mutation of these residues could impede the blocking of 
this intersubunit bridge by IF3mt, preventing these mutated forms of IF3mt from effectively 
competing with the 39S subunit for binding to the 28S subunit. 
There are two current models to explain the action of IF3mt in ribosomal subunit 
dissociation (Figure 2-14).  In the passive model, IF3mt binds to 28S subunits after the 
subunits dissociate transiently (Figure 2-14A, passive model).  In this model, IF3mt acts more 
as an anti-association factor than a dissociation factor (31).  In the active model, an 
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equilibrium exists between 55S ribosomes and a transient 28S:IF3mt:39S complex (Figure 2-
14B, active step 1).  This transient complex is in equilibrium with free 39S subunits and 28S 
subunits bound to IF3mt (active step 2). The active model suggests that IF3mt plays a more 
direct role in dissociating 55S ribosomes than simply binding to 28S subunits that are 
present at equilibrium.  IF3mt: 5 and IF3mt:6, though they bind well to 28S subunits (active 
step 1), are deficient in dissociating 55S ribosomes (active step 2).  This observation 
suggests that a transient 28S:IF3mt:39S complex formed by these mutated derivatives fails 
to dissociate into its component subunits.  This idea is supported by recent kinetic data, 
which suggest that in E. coli, IF3 may remain associated with the 30S subunit that is partially 
bound to the 50S subunit (27), and by recent cryo-electron microscopy data, which 
tentatively suggests that IF3 may not be released from 70S particles until the hydrolysis of 
GTP by IF2 has occurred (32).The present results suggest that IF3mt plays an active role 
rather than a passive role in ribosomal subunit dissociation in the mitochondrial 
translational system.    
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CHAPTER 3 
 
PREFERENTIAL SELECTION OF THE 5’ TERMINAL START CODON ON LEADERLESS mRNAS BY 
BOVINE MITOCHONDRIAL RIBOSOMES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work from this chapter is in preparation to be submitted for publication.
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INTRODUCTION 
In contrast to other genomes, the mammalian mitochondrial genome is very 
compact, containing approximately 16 kilobase pairs of DNA.  It codes for 2 rRNAs, 13 
proteins, and 22 tRNAs (1).  The 13 proteins are components of the electron transport chain 
and ATP synthase.  Very few non-coding regions exist in the mitochondrial genome.  A 
maximum of 3 nucleotides are observed prior to the start codon in human mitochondrial 
mRNAs (2). 
 Initiation of protein synthesis in mitochondria has several similarities to that in 
prokaryotes, but this system is also characterized by a number of unique features.  
Mitochondrial monosomes sediment at 55S and dissociate to form 28S and 39S subunits.  
The mitochondrial SSU has a unique mRNA entrance gate composed of one or more 
mitochondrial-specific proteins and the SSU protein MRPS2.  MRPS2 is the homolog of the 
bacterial ribosomal protein S2 but is larger in the mitochondrial ribosome (3).  These 
proteins come together to form a triangular mRNA entrance site, which may play a role in 
binding mitochondrial leaderless mRNAs.  Protein synthesis in mitochondria occurs with the 
help of two initiation factors:  IF2mt promotes the binding of fMet-tRNA to 28S small 
ribosomal subunits, and IF3mt stimulates initiation complex formation by aiding in the 
dissociation of mitochondrial 55S ribosomes.  No factor homologous to prokaryotic IF1 has 
been found in mitochondria. 
 An important difference between bacterial and mitochondrial translational initiation 
is the process by which the start codon of the mRNA is placed in the P-site of the ribosome.  
In prokaryotes, a SD sequence is present that hydrogen bonds with nucleotides near the 3’ 
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end of the 16S rRNA (ASD) (4).  These interactions help to properly position the mRNA on 
the ribosome.  Because mitochondrial mRNAs are largely leaderless, the mechanism of the 
selection of the translational start site must be different from that in prokaryotes.   
Leaderless mRNAs, in addition to being translated in mitochondria, are also 
translated in bacteria and archaea, although each system has unique mechanisms reported 
for initiation on these leaderless messages.  In the archaeal system, two-thirds of all mRNAs 
are leaderless, and few of the mRNAs that contain leaders contain SD sequences (5).  In 
certain archaeal systems, introduction of an internal AUG to a leaderless mRNA resulted in 
translation from both the 5’ AUG and the internal AUG, although it has not been 
determined whether initiation could occur on both AUGs simultaneously (6). 
A recent study on the translation of leaderless mRNA in prokaryotes revealed that 
ribosomes devoid of a number of proteins (61S particles) were specific for translating only 
leaderless mRNAs (7).  However, of the 14 ribosomal proteins that are conserved between 
the small subunit of mitochondrial and prokaryotic systems, 11 are lost in the formation of 
the prokaryotic 61S particles.  This observation indicates that the mechanism by which 
prokaryotic ribosomes translate leaderless mRNAs is likely to be different from the 
mechanism of translational initiation in mitochondria. 
In prokaryotes, it is unclear whether initiation of leaderless mRNAs occurs on intact 
70S monosomes or on dissociated 30S subunits (8-10).  Bacterial IF3 has been shown to 
reduce translational efficiency on leaderless mRNAs that begin with a 5’ AUG when present 
in excess (11).  However, at low concentrations, E. coli IF3 increased the number of 
initiation complexes formed on leaderless mRNAs (8).  In agreement with the latter 
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observation, IF3mt stimulates initiation complex formation on the leaderless mitochondrial 
mRNAs, suggesting that initiation on these mRNAs does not require an intact monosome 
(12). 
 Previous data has indicated that mitochondrial mRNAs will bind nonspecifically to 
the mitochondrial 28S SSU alone, without the help of initiation factors (13).  It was also 
determined that, in the absence of initiation factors, shorter mRNAs (fewer than 400 
nucleotides) bind less well to mitochondrial 28S subunits than longer mRNAs (14).   SHAPE 
analysis of mitochondrial mRNAs indicated that the 5’ ends of these mRNAs contain little or 
no secondary structure (15).   Thus, it is unclear how the start codon of mitochondrial 
mRNAs is correctly positioned on the ribosome.  The focus of this chapter is to investigate 
the selection of a 5’ AUG start codon on mitochondrial mRNAs. 
 
MATERIALS AND METHODS 
Materials 
General chemicals were purchased from Sigma-Aldrich or Fisher Scientific.  Bovine 
mitochondrial ribosomes (55S), ribosomal subunits (28S and 39S), and yeast [35S]fMet-tRNA 
were prepared as described (3;16-18).  IF2mt and IF3mt were cloned, expressed, and purified 
as described previously (19).  Both proteins were purified by HPLC following Ni-NTA 
chromatography as described (19). 
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Cloning Cytochrome Oxidase Subunit I (CoI), NADH Dehydrogenase Subunit 2 (ND2), and 
Met-tRNA/ND2 fragments 
The first 151 nucleotides of CoI DNA, the first 150 nucleotides of ND2 DNA, and the 
entire tRNAMet plus the first 150 nucleotides of ND2 were amplified using PCR from the 
plasmid p11-1 (20), which contains bovine mitochondrial DNA from nucleotides 15,743 – 
8,788.  Primers used for amplification incorporated the sequence for the Hind III restriction 
site, the T7 promoter, and a hammerhead ribozyme (ACATCTGATGAGTCCGTGAGGACGAAA 
CGGTACCCGGTACCGTC; shaded nucleotides vary and are complementary to the first 
nucleotides of each transcribed sequence) followed by nucleotides for the sequence of 
interest.  The hammerhead ribozyme system was used to generate leaderless mRNAs via 
self-cleavage prior to the first nucleotide of each sequence (21).  The primers also 
incorporated an XbaI restriction site on the 3’ end of the DNA sequence.  The sequences for 
all primers and thermocycler conditions used are provided in Table 3-1 and 3-2, 
respectively.  Ten different constructs were prepared using the sequence for CoI DNA, 
including: 5’ AUG mRNA, AUG68 mRNA, Both AUG mRNA, 0 AUG mRNA, 1mer-AUG mRNA, 
2mer-AUG mRNA, 3mer-AUG mRNA, 6mer-AUG mRNA, 9mer-AUG mRNA, and 12mer-AUG 
mRNA (Figure 3-1).  Three different constructs were prepared using the sequence for NADH 
Dehydrogenase Subunit 2 (ND2), including: ND2 5’ AUG mRNA, ND2 AUG91 mRNA, and ND2 
0 AUG mRNA (Figure 3-1).  A hybrid mRNA was prepared using the sequence for tRNAMet 
attached at the 5’ end to the first 150 nucleotides of ND2 (Figure 3-1).   
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The first construct prepared was the CoI 5’ AUG mRNA.  For this construct, the first 
151 nucleotides of CoI were amplified from the p11-1 plasmid with primers that added the 
hammerhead ribozyme sequence to the 5’ end of the CoI sequence and an XbaI restriction 
site to the 3’ end of the CoI sequence.  A second PCR reaction was then performed using the 
amplified product from the first reaction and added a portion of the T7 promoter sequence 
to the 5’ end of the hammerhead ribozyme sequence.  Finally, a third amplification was 
performed using the second amplified product above to incorporate the full T7 promoter 
sequence and a HindIII restriction site on the 5’ end of the T7 promoter sequence.  The 
resulting construct was then digested with both HindIII and XbaI and ligated into 
HindIII/XbaI digested pUC19.  The University of North Carolina at Chapel Hill Genome 
Analysis Facility was used to confirm all sequences.   
The Both AUG construct was prepared using the QuikChange site-directed 
mutagenesis kit (Stratagene) to change an internal GTG of the 5’ AUG construct to AUG, 
resulting in a DNA sequence with two ATGs.  The 3’ AUG construct was prepared by 
mutating the 5’ ATG of the 5’ AUG construct to GCG.  To make the 3’ AUG construct 
cleavable by the hammerhead ribozyme, it was also necessary to change the first four 
nucleotides of the hammerhead sequence (indicated as variable above) to ACGC.  To 
prepare the 0 AUG construct, the 5’ AUG construct was mutated to change the ATG to GTG, 
and the variable nucleotides were changed to ACGC to make the hammerhead ribozyme 
functional.  The 5’ extended mRNAs constructs were prepared by adding nucleotides to the 
5’ AUG construct using the QuikChange site-directed mutagenesis kit (Stratagene), and the 
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variable nucleotides were mutated to make the hammerhead ribozyme functional in each 
case.  
The tRNAMet/ND2 and ND2 constructs were prepared using the p11-1 starting 
plasmid and sequential PCR reactions (similar to those used for the CoI constructs) that 
resulted in a 5’ AUG construct containing a HindIII restriction enzyme site, the T7 promoter, 
the hammerhead ribozyme, the first 150 nucleotides of ND2, and an XbaI restriction site 
(Table 2-1).  Since ND2 begins with an ATA in the genome, an additional mutagenesis step 
was necessary to change the ATA to an ATG.  
 
Table 3-1.  Summary of primers used for the preparation of CoI, ND2, and tRNAMet/ND2 
mRNA constructs.  Added nucleotides are shaded in dark grey, and mutated nucleotides are 
shaded in light grey.  The hammerhead ribozyme sequence is underlined, and the first four 
variable nucleotides are shaded in blue. 
CoI Constructs 
Construct Primer 
5’ AUG mRNA 
 
Starting plasmid: p11-1 
Forward:  
ACATCTGATGAGTCCGTGAGGACGAAACGGTACCCGGTACCGTCATG
TTCATTAACCGCTG 
Reverse: CTAGTCTAGACGTCTCCGAGCAGAGTTC 
Thermocycler condition 1 
Forward:  CTAGAAGCTTGGGAGAACATCTGATGAGTCCGTG   
Reverse:  Same as above 
Thermocycler condition 2 
Forward: 
CTAGAAGCTTTAATACGACTCACTATAGGGAGAACATCTGATG 
Reverse: Same as above 
Thermocycler condition 1 
Both AUG mRNA 
Starting plasmid: 5’ AUG mRNA 
Forward: CCTTTATCTACTATTTGATGCTTGGGCCGGTATAGTAGG 
Reverse: CCTACTATACCGGCCCAAGCATCAAATAGTAGATAAAGG 
Thermocycler: Mutagenesis 53, 54, 55, then 16 
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AUG68 mRNA 
Starting plasmid: Both AUG mRNA 
Forward: CCCGGTACCGTCGCGTTCATTAACCGCTG 
Reverse: CAGCGGTTAATGAACGCGACGGTACCGGG 
Thermocycler condition 3 
HH complementary 
Forward: CACTATAGGGAGAACGCCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGGCGTTCTCCCTATAGTG 
Thermocycler condition 3 
0 AUG mRNA 
Starting plasmid: 5’ AUG mRNA 
Forward and Reverse: same as 3’ AUG mRNA 
Thermocycler condition 3 
HH complementary 
Forward and Reverse same as 3’ AUG mRNA 
Thermocycler condition 3 
1mer-AUG mRNA 
Starting plasmid: 5’ AUG mRNA 
Forward: CGGTACCCGGTACCGTCGATGTTCATTAACCGCTG 
Reverse: CAGCGGTTAATGAACATCGACGGTACCGGGTACCG 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGACATCCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGGATGTCTCCCTATAGTGAG 
Thermocycler condition 3 
2mer-AUG mRNA 
Starting plasmid: 5’ AUG mRNA 
Forward: CGGTACCCGGTACCGTCUGATGTTCATTAACCGCTG 
Reverse: CAGCGGTTAATGAACATCAGACGGTACCGGGTACCG 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGAATCACTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGTGATTCTCCCTATAGTGAG 
Thermocycler condition 3 
3mer-AUG mRNA 
Forward: GTACCCGGTACCGTCCTGATGTTCATTAACCGC   
Reverse: GCGGTTAATGAACATCAGGACGGTACCGGGTAC 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGATCAGCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGCTGATCTCCCTATAGTGAG 
Thermocycler condition 3 
6mer-AUG mRNA 
Forward: GTACCCGGTACCGTCCCACTGATGTTCATTAACCGC   
Reverse: GCGGTTAATGAACATCAGTGGGACGGTACCGGGTAC 
Thermocycler condition 3 
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ND2 Constructs 
Construct Primer 
tRNAMet/ND2 
Starting plasmid: p11-1 
Forward: 
TACTCTGATGAGTCCGTGAGGACGAAACGGTACCCGGTACCGTCAGTA
AGGTCAGCTAATTAAGC 
Reverse: CTAGTCTAGATGGGTTGTGATTTTTTATTATGATGGGG 
Thermocycler condition 4 
Forward: CTAGAAGCTTGGGAGATACTCTGATGAGTCCGTG 
Reverse: same as above 
Thermocycler condition 5 
Forward: 
CTAGAAGCTTTAATACGACTCACTATAGGGAGATACTCTGATGAGTCCG 
Reverse: same as above 
Thermocycler condition 5 
Change AUA to AUG: 
Forward: CCTTCCCGTACTAATGAACCCAATTATC 
Reverse: GATAATTGGGTTCATTAGTACGGGAAGG 
Thermocycler condition 3 
HH complementary 
Forward: CTCACTATAGGGAGAGTGGCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGCCACTCTCCCTATAGTGAG 
Thermocycler condition 3 
9mer-AUG mRNA 
Starting plasmid: CoI 6mer-AUG mRNA 
Forward: CGGTACCCGGTACCGTCCCGCCACTGATGTTCATTAACCG 
Reverse: CGGTTAATGAACATCAGTGGCGGGACGGTACCGGGTACCG 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGAGCGGCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGCCGCTCTCCCTATAGTGAG 
Thermocycler condition 3 
12mer-AUG mRNA 
Starting plasmid: CoI 9mer-AUG mRNA 
Forward: 
CGGTACCCGGTACCGTCTCACCGCCACTGATGTTCATTAACCG 
Reverse: 
CGGTTAATGAACATCAGTGGCGGTGAGACGGTACCGGGTACCG 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGAGTGACTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGTCACTCTCCCTATAGTGAG 
Thermocycler condition 3 
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ND2 5’ AUG 
mRNA 
Starting plasmid: p11-1 
Forward: 
CCGTGAGGACGAAACGGTACCCGGTACCGTCATAAACCCAATTATCTTT
ATTATTATTCTAC 
Reverse: CTAGTCTAGATGGGTTGTGATTTTTTATTATGATGGGG 
Thermocycler condition 6 
Forward: 
CTATAGGGAGATTATCTGATGAGTCCGTGAGGACGAAACGGTACCC 
Reverse: same as above 
Thermocycler: condition 7 
Forward: 
CTAGAAGCTTTAATACGACTCACTATAGGGAGATTATCTGATG 
Reverse: same as above 
Thermocycler condition 8 
Change AUA to AUG: 
Forward: GGTACCCGGTACCGTCATGAACCCAATTATC 
Reverse: GATAATTGGGTTCATGACGGTACCGGGTACC 
Thermocycler condition 3 
HH Complementary 
Forward: CTCACTATAGGGAGATCATCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGATGATCTCCCTATAGTGAG 
Thermocycler condition 3 
ND2 AUG91 
mRNA 
Starting plasmid: ND2 0 AUG mRNA 
Forward: CTGACTACTTGTCTGAATGGGGTTTGAAATAAATATAC 
Reverse: GTATATTTATTTCAAACCCCATTCAGACAAGTAGTCAG 
ND2 0 AUG 
mRNA 
Starting plasmid: ND2 5’ AUG mRNA 
Forward: GGTACCCGGTACCGTCGCGAACCCAATTATC 
Reverse: GATAATTGGGTTCGCGACGGTACCGGGTACC 
Thermocycler condition 3 
HH complementary 
Forward: CTCACTATAGGGAGATCGCCTGATGAGTCCGTGAG 
Reverse: CTCACGGACTCATCAGGCGATCTCCCTATAGTGAG 
Thermocycler condition 3 
 
 
Table 3-2.  Thermocycler conditions used for preparation of mRNA constructs listed in Table 
3-1. 
Thermocycler conditions 1 
Time Temperature What for? Number of cycles 
30 seconds 90°C Denaturation 
5 30 seconds 42°C Annealing Primers 
60 seconds 72°C Extension 
30 seconds 90°C Denaturation 30 
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30 seconds 60°C Annealing Primers 
60 seconds 72°C Extension 
Thermocycler conditions 2 
Time Temperature What for? Number of cycles 
30 seconds 90°C Denaturation 
5 30 seconds 50°C Annealing Primers 
60 seconds 72°C Extension 
30 seconds 90°C Denaturation 
30 30 seconds 65°C Annealing Primers 
60 seconds 72°C Extension 
Thermocycler conditions 3 
Time Temperature What for? Number of cycles 
30 seconds 95°C Initial Denaturation 1 
60 seconds 95°C Denaturation 
5 60 seconds 60°C Annealing Primers 
13 minutes 68°C Extension 
60 seconds 95°C Denaturation 
16 60 seconds 55°C Annealing Primers 
10 minutes 68°C Extension 
Thermocycler conditions 4 (gradient thermocycler) 
Time Temperature What for? Number of cycles 
3 min 95°C 
Initiatial 
denaturation 
1 
30 seconds 95°C Denaturation 
5 30 seconds 45°C±10°C Annealing Primers 
60 seconds 70°C Extension 
30 seconds 95°C Denaturation 
30 30 seconds 60°C Annealing Primers 
60 seconds 70°C Extension 
10 minutes 70°C Final Extension 1 
Thermocycler conditions 5 
Time Temperature What for? Number of cycles 
1 minute 95°C 
Initiatial 
denaturation 
1 
30 seconds 95°C Denaturation 
5 30 seconds 50° Annealing Primers 
60 seconds 72°C Extension 
30 seconds 95°C Denaturation 
30 30 seconds 65°C Annealing Primers 
60 seconds 72°C Extension 
10 minutes 70°C Final Extension 1 
Thermocycler conditions 6 
Time Temperature What for? Number of cycles 
3 minutes 95°C Initial denaturation 1 
30 seconds 95°C Denaturation 
5 30 seconds 38.4° Annealing Primers 
60 seconds 70°C Extension 
30 seconds 95°C Denaturation 
30 30 seconds 60°C Annealing Primers 
60 seconds 70°C Extension 
10 minutes 70°C Final Extension 1 
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Figure 3-1.  Summary of cytochrome oxidase subunit I (CoI), NADH dehydrogenase 
subunit II (ND2), and tRNAMet/ND2 mRNA constructs.  The mRNAs prepared for both CoI 
and ND2 that contained either a 5’ AUG, an internal AUG, or both a 5’ and an internal 
AUG.  A control mRNA was also prepared for each mRNA that did not contain any AUG 
codons.  CoI mRNAs with additional nucleotides 5’ to the start codon were also 
prepared. 
AUG AUG Both AUG mRNA
AUG68 mRNAAUGGCG
AUG 5’ AUG mRNAGUG
0 AUG mRNAGCG GUG
GAUG 1mer-AUG mRNAGUG
UGAUG 2mer-AUG mRNAGUG
CUGAUG 3mer-AUG mRNAGUG
CCACUGAUG 6mer-AUG mRNAGUG
CCGCCACUGAUG 9mer-AUG mRNAGUG
UCACCGCCACUGAUG 12mer-AUG mRNAGUG
AUG 5’ AUG mRNAAUC
GCG AUG91 mRNAAUG
GCG 0 AUG mRNAAUC
AUG tRNAMet/ND2mRNAAUC
681
911
Cytochrome
oxidase subunit I 
(CoI) mRNAs
NADH 
Dehydrogenase
Subunit II (ND2) 
mRNAs
Thermocycler conditions 7 
Time Temperature What for? Number of cycles 
30 seconds 95°C Denaturation 
5 30 seconds 59°C Annealing Primers 
60 seconds 70°C Extension 
30 seconds 95°C Denaturation 
30 30 seconds 65°C Annealing Primers 
60 seconds 70°C Extension 
Thermocycler conditions 8 
Time Temperature What for? Number of cycles 
30 seconds 95°C Denaturation 
5 30 seconds 48°C Annealing Primers 
60 seconds 70°C Extension 
30 seconds 95°C Denaturation 
30 30 seconds 65°C Annealing Primers 
60 seconds 70°C Extension 
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Table 3-3.  Full sequences of CoI, ND2, and tRNAMet/ND2 mRNA constructs.  The AUG 
codons are shown in red and the tRNAMet sequence is shown in blue. 
 
mRNA Sequence 
CoI 
5’ AUG mRNA AUGUUCAUUAACCGCUGACUAUUCUCAACCAGCCAUAAAGAUAUUGGUACCCU
UUAUCUACUAUUUGGUGCUUGGGCCGGUAUAGUAGGAACAGCUCUAAGCCUU
CUAAUUCGCGCUGAAUUAGGCCAACCCGGAACUCUGCUCGGAGACG 
ND2 
5’ AUG mRNA AUGAACCCAAUUAUCUUUAUUAUUAUUCUACUAACCAUUAUACUAGGAACUA
UUAUUGUCAUAAUCAGUUCUCACUGACUACUUGUCUGAAUCGGGUUUGAAAU
AAAUAUACUCGCCAUCAUCCCCAUCAUAAUAAAAAAUCACAACCCA 
tRNAMet/ND2 
mRNA 
AGUAAGGUCAGCUAAUUAAGCUAUCGGGCCCAUACCCCGAAAAUGUUGGUUU
AUAUCCUUCCCGUACUAAUGAACCCAAUUAUCUUUAUUAUUAUUCUACUAACC
AUUAUACUAGGAACUAUUAUUGUCAUAAUCAGUUCUCACUGACUACUUGUCU
GAAUCGGGUUUGAAAUAAAUAUACUCGCCAUCAUCCCCAUCAUAAUAAAAAAU
CACAACCCAUCUAGA 
   
Synthesis of mRNAs 
Plasmid DNA was linearized by digestion with XbaI, extracted using 
phenol/chloroform, and precipitated with ethanol before use.  In vitro transcription 
reactions were prepared basically as described using 25-50 µg DNA (13).  Prior to 
hammerhead cleavage, transcription reactions were diluted 5X in a cleavage buffer 
containing 30 mM MgCl2 and 40 mM Tris-HCl (pH 7.6).  Hammerhead cleavage was allowed 
to proceed for 1 h at 60 °C, at which time 2X RNA load dye (Ambion) was added to the 
reactions and the transcribed mRNAs were separated from the cleaved hammerhead 
fragments by gel electrophoresis using an 8% polyacrylamide/7 M urea gel.  Full-length 
mRNA transcripts were excised from the gel and eluted in RNase free H2O (Ambion) for 48 h 
at 4 °C.  The concentration of each mRNA was determined by measuring the A260.  The 
sequences of all mRNA constructs used are summarized in Table 3-3.   
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Phosphorylation of mRNAs 
CoI 5’AUG and CoI AUG68 mRNAs were phosphorylated in reactions (500 µL) that 
contained 100 U T4 polynucleotide kinase (New England Biolabs), 50 µL 10X T4 
polynucleotide kinase buffer (New England Biolabs), 50 µg BSA, 1 mM ATP, and 1.25 nmol 
mRNA.  Reactions were incubated at 37 °C for 1 h, extracted using phenol/chloroform and 
the RNA was precipitated with ethanol.  Excess ATP was removed from the phosphorylated 
mRNAs by using a Mini Quick Spin RNA Column (Roche). 
 
Initiation Complex Formation on Mitochondrial Ribosomes 
Stimulation of fMet-tRNA binding to mitochondrial 55S ribosomes or 28S subunits 
was examined using a filter binding assay.  Reaction mixtures (50 µL) were prepared as 
described previously (see Chapter 2) (18;22) and contained the indicated amounts of mRNA, 
[35S]fMet-tRNA (70 nM), 0.25 mM GTP, 1.25 mM PEP, 0.04 U pyruvate kinase, saturating 
amounts of IF3mt (0.25 µM) and IF2mt (0.15 µM), and 55S ribosomes (80 nM) or 28S 
ribosomal subunits (80 nM).  IF3mt was not present in assays using 28S subunits unless 
otherwise indicated. 
 
Competition Assays 
The ability of CoI AUG68 mRNA to compete with CoI 5’ AUG mRNA for mitochondrial 
55S ribosome binding was tested in a competition assay.  55S initiation complex assays 
were performed as described above, except that mixtures of CoI 5’ AUG and CoI AUG68 
mRNAs were prepared using 0.1 µM 5’ AUG mRNA in the following ratios to AUG68 mRNA: 
71 
 
1:0, 1:1, 1:1.5, 1:2, 1:5, and 1:10.  The mRNAs were mixed together prior to being added to 
the reaction.  Reactions were incubated at 37 °C for 10 min and processed as described 
above. 
 
Toeprints 
 Binding of mitochondrial 55S ribosomes to mRNA was examined using a toeprint 
assay.  Reaction mixtures (20 µL) contained 50 mM Tris-HCl (pH 8.0), 10 mM DTT, 7 mM 
MgCl2, 40 mM KCl, 0.1 mM spermine, 0.25 mM GTP, 1.25 mM PEP, 0.04 U pyruvate kinase, 
0.5 mM dNTPs, 0.4 µM fMet-tRNA, 0.4 µM IF2mt, 0.4 µM IF3mt, 0.3 µM mitochondrial 55S 
ribosomes, 50 nM [32P] labeled primer ([32P] labeled primer with the sequence: CGT CTC 
CGA GCA GAG was prepared as described previously (15) and gel-purified using a 20% 
polyacrylamide/7 M urea gel), 50 nM mRNA (CoI 5’ AUG, AUG68, Both AUG, or 0 AUG 
mRNA).  Reactions were incubated at 37 °C for 10 min, at which time 200 U Superscript III 
reverse transcriptase (Invitrogen) were added, and reverse transcription was allowed to 
proceed at 37 °C for 10 min.  The reactions were stopped by the addition of 2 µL 2 M NaOH 
and then heated for 5 min at 95 °C.  The reactions were neutralized by the addition of 29 µL 
acid stop mix (4:25 (v/v) mix of 1 M unbuffered Tris-HCl and stop dye: 85 % formamide, ½X 
Tris-Borate-EDTA (TBE), 50 mM EDTA (pH 8), bromophenol blue, and xylene cyanol).  One 
half of each reaction was then loaded onto a 10% polyacrylamide/7 M urea gel and run at 
1550 V for 3 h.  At this time, the other half of each reaction was loaded into separate wells 
and the gel was run at 1550 V for another 3 h.  The gel was exposed to a phosphorimager 
screen overnight and then scanned using a Typhoon Trio + (GE Healthcare) variable mode 
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Figure 3-2.  Initiation complex formation on 
mitochondrial 55S ribosomes and 28S subunits using 
CoI mRNAs.  [35S]fMet-tRNA binding to mitochondrial 
55S particles was tested in the presence of increasing 
amounts of 5’ AUG, AUG68, Both AUG, or 0 AUG 
mRNA. A blank (~0.08 pmol) corresponding to the 
amount of fMet-tRNA bound to ribosomes in the 
absence of mRNA was subtracted from each value.   
imager.  Images were analyzed using ImageQuant software.  Control reactions to determine 
non-specific enzyme stops were performed in the absence of 55S ribosomes.  Sequencing 
reactions were performed using 0.5 mM dNTPs, 2 µL 5X Superscript III Reverse Transcription 
Buffer (Invitrogen), 0.5 mM ddNTP (A or C), 50 nM [32P] labeled primer, and 50 nM mRNA 
(CoI 5’ AUG).  Sequencing reactions were incubated at 52 °C for 10 min, at which time the 
reactions were stopped by the addition of 1 µL 2 M NaOH, heated for 5 min at 95 °C, and 
neutralized by addition of 14.5 µL acid stop mix. 
 
RESULTS 
The Mitochondrial Ribosome Discriminates Between a 5’ AUG and an Internal AUG Codon 
 Since many 
mitochondrial mRNAs have the 
start codon located exactly at 
the 5’ end, transcription of CoI 
mRNAs was coupled with 
hammerhead ribozyme 
cleavage to generate mRNAs 
with the AUG precisely 
positioned at the 5’ end.  
Additional mRNAs were 
prepared that contained an 
internal AUG at position 68 
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(AUG68), two AUGs (Both AUG mRNA, one at the 5’ end and one at position 68), or no AUG 
codon (0 AUG mRNA).  Initiation complex formation assays were carried out using each 
mRNA.  Initiation complex formation on the 5’ AUG mRNA and the Both AUG mRNA was 
stimulated as mRNA levels were increased (Figure 3-2).  In contrast, no initiation complexes 
were formed on 55S ribosomes using either the AUG68 mRNA or the 0 AUG mRNA.  This 
observation indicates that the ribosome discriminates between mRNAs that contain start 
codons at their 5’ end and those that do not.  The same discrimination was seen on 55S 
ribosomes when IF3mt was excluded from the initiation assay (Table 3-4), although the 
amount of binding was reduced in the absence of IF3mt due to a limitation in ribosome 
dissociation.  This observation suggests that IF3mt is not necessary for the ribosomal 
discrimination of a 5’ AUG start codon from an internal AUG codon.  
 
Table 3-4.  Effect of IF3mt on selection of a 5’ AUG by bovine mitochondrial 55S ribosomes.  
All four CoI mRNA constructs were tested for [35S]fMet-tRNA binding in the presence and 
absence of IF3mt.  No blank corresponding to the amount of [
35S]fMet-tRNA bound to the 
ribosome in the absence of mRNA was subtracted, leading to values greater than those 
reported in Figure 3-2.  The estimated error in these experiments is 10%. 
 
mRNA 
pmol [35S]fMet-tRNA 
bound 
+ or – IF3 
5’AUG 0.17 - IF3 
5’AUG 0.26 + IF3 
AUG68 0.05 - IF3 
AUG68 0.08 + IF3 
Both AUG 0.20 - IF3 
Both AUG 0.31 + IF3 
0 AUG 0.06 - IF3 
0 AUG 0.08 + IF3 
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Figure 3-3.  [35S]fMet-tRNA binding to mitochondrial 28S subunits 
tested in the presence of increasing amounts of 5’ AUG, AUG68, 
Both AUG, or 0 AUG mRNA.  A blank (~0.04 pmol) corresponding 
to the amount of fMet-tRNA bound to 28S subunits in the 
absence of mRNA was subtracted from each value. 
 It is unclear in the mitochondrial system whether initiation occurs on 55S 
monosomes or 28S subunits.  Hence, initiation assays were also performed using 28S 
subunits.  IF3mt was 
not present in these 
assays, since it was 
not shown to affect 
discrimination by 
55S ribosomes and 
does not stimulate 
initiation complex 
formation on 28S 
SSUs (Figure 3-3) 
(22).  Initiation on 
28S subunits was 
stimulated by increasing amounts of the 5’ AUG and Both AUG mRNAs, as was seen on 55S 
ribosomes (Figure 3-3).  However, no initiation complex formation on 28S subunits was seen 
using the 0 AUG mRNA, and only a small level of initiation complex formation was observed 
with the AUG68 mRNA (10-15%).  These observations indicate that the ability to 
preferentially use a 5’ AUG over an internal AUG is an intrinsic property of the 28S subunit.  
This idea is in agreement with the observation that mRNA binds exclusively to the small 
subunit (13). 
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Figure 3-4.  Toeprints showing the position of the 55S ribosome on the 5’ AUG 
mRNA and AUG68 mRNA.  Toeprint assays were performed as described in 
Materials and Methods.  Control reactions were performed in the absence of 
either fMet-tRNA and IF2mt or 55S ribosomes.  Sequencing reactions were 
carried out using ddCTP and ddATP.  Nucleotide G14 is numbered from the 5’ 
end of the mRNA.   
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Toeprint Analysis of the Mitochondrial 55S Initiation Complex 
 To directly analyze the position of the ribosome on the mRNA in the initiation 
complex, a series of toeprint reactions was performed using CoI mRNAs (Figure 3-4 and 
Figure 3-5).  In the absence of 55S ribosomes, a reverse transcriptase stop is seen at 
position 20 of the mRNA due to a non-specific stop of the enzyme (Figure 3-4, lanes 1-8).  
When initiation complexes were assembled with the 5’ AUG mRNA, a clear and repeatable 
toeprint of the ribosome was seen 17-19 nucleotides from the 5’ end of the mRNA (Figure 
3-4 lane 2).  This position corresponds to the distance from the edge of the mRNA entrance 
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tunnel to the P-site.  This observation agrees with previous data that indicates that the 
prokaryotic ribosome produces a toeprint signal at nucleotide 15 (23).  The mitochondrial 
ribosome is slightly larger in size than its prokaryotic counterpart and is expected to cover a 
slightly larger section of the mRNA (3).  Further, in non-specific complexes between 28S 
subunits and mitochondrial mRNAs, a region of about 45 nucleotides of the mRNA was 
protected from degradation by RNAse T1 (13).  This value represents the distance between 
the mRNA entrance tunnel and the point where the mRNA exits the SSU through the 
platform.  Since the P-site is close to the center of the small subunit, the toeprint signal 
observed here is at a reasonable position for a ribosome positioned at the 5’ end of the 
mRNA.   
In the absence of IF2mt and fMet-tRNA, the toeprint signal is drastically reduced 
(Figure 3-4, lane 3), indicating that both are required to stably position the ribosome at the 
5’ end of the mRNA.  However, a weak signal is observed at position 17.  When the 5’ AUG 
was removed and an AUG was present at position 68, a toeprint signal at nucleotide 17 was 
present but very weak and was identical in appearance to the toeprint signal in the absence 
of IF2mt and fMet-tRNA on the 5’ AUG mRNA (Figure 3-4, lanes 3 and 5).  This signal appears 
to arise from an intrinsic interaction between the mRNA and the ribosome and may 
represent a signal from a transient complex in which the 5’ end of the mRNA has been fed 
into the mRNA entrance site and the first codon of the mRNA is transiently positioned at or 
near the P-site.  The strong toeprint signal at nucleotides 18 and 19 was not present in the 
AUG68 mRNA (Figure 3-4, lane 5).  No toeprint signal was observed corresponding to the 
edge of a ribosome bound at the internal AUG, which would be at nucleotide 85-87 (data 
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Figure 3-5. Toeprints showing the position of the 55S ribosome on the 5’ AUG 
mRNA in the presence and absence of IF2mt and fMet-tRNA.  Toeprint assays 
were performed as described in Materials and Methods.  Control reactions 
were performed in the absence of either fMet-tRNA and IF2mt or 55S 
ribosomes.  Sequencing reactions were carried out using ddCTP and ddATP.  
Nucleotide G14 is numbered from the 5’ end of the mRNA.   
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not shown). The toeprint with the Both AUG mRNA was the same as that observed for the 
5’ AUG mRNA.  A toeprint at nucleotide 17 only was seen using the 0 AUG mRNA (data not 
shown). 
 The importance of fMet-tRNA and IF2mt on the ability of the 55S ribosome to bind 
specifically to the 5’ end of the mRNA was also examined using the toeprint assay.  In the 
absence of both fMet-tRNA and IF2mt, a weak toeprint signal is seen at the position of 
nucleotide 17 (Figure 3-5, lane 3).  This signal agrees with previous data showing that mRNA 
can bind to the small subunit of the mitochondrial ribosome in the absence of initiation 
factors or tRNA and suggests that the mRNA most likely binds to the ribosome prior to the 
binding of fMet-tRNA or IF2mt (13).  This signal is strengthened by the addition of fMet-tRNA 
in the absence of IF2mt (Figure 3-5, lane 4), but is unaffected by the addition of IF2mt alone 
(Figure 3-5, lane 5).  This data argues that IF2mt, as expected, enhances fMet-tRNA binding 
to the ribosome and stabilizes the formation of the initiation complex at the 5’ AUG codon, 
78 
 
mRNA (pmol)
1 3 5 7 9 11
fM
e
t-
tR
N
A
 b
o
u
n
d
 (
p
m
o
l)
0.01
0.03
0.05
0.07
0.09
0.11
0.13
P 5' AUG mRNA
P 3' AUG mRNA
Figure 3-6.  Effect of phosphorylation of the 5’ end of CoI mRNA 
on inititiation complex formation on 55S ribosomes.  
Phosphorylated mRNAs were prepared as described in Materials 
and Methods.  [35S]fMet-tRNA binding to mitochondrial 55S 
particles was tested in the presence of increasing amounts of 
phosphorylated 5’ AUG and phosphorylated AUG68 mRNAs.  The 
saturation level of this experiment is lower than that in Figure 3-2 
due to the percentage of active ribosomes. 
leading to the strong toeprint at positions 17-19.  The data also suggests that the additional 
stabilization of the initiation complex provided by codon/anticodon interactions between 
the fMet-tRNA and the mRNA are important for the discrimination of the 5’ AUG by the 
ribosome. 
 
Effect of a 5’ Phosphate on Initiation Complex Formation at a 5’ AUG 
 Mammalian mitochondrial mRNAs are synthesized as long transcripts and are 
subsequently cleaved to produce mature rRNAs, tRNAs, and mRNAs (24).  This post-
transcriptional mRNA processing produces a free phosphate group at the 5’ end of the 
mRNA.  All mRNAs 
studied above were 
synthesized using in 
vitro transcription 
and then 
subsequently 
exposed to 
hammerhead RNA 
cleavage.  Because 
hammerhead 
cleavage leaves the 
mRNAs with a free 
5’ hydroxyl group 
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Figure 3-7.  Competition of CoI AUG68 mRNA with 5’ AUG mRNA 
for initiation complex formation on mitochondrial 55S 
ribosomes.  [35S]fMet-tRNA binding to mitochondrial 55S 
particles was tested in the presence of both CoI 5’ AUG and 
AUG68 mRNAs simultaneously.  5’ AUG mRNA and AUG68 mRNA 
were mixed together prior to their additions to the reaction.  
The molar ratio of the AUG68 mRNA divided by the 5’ AUG 
mRNA is shown on the x-axis. 
instead of a 5’ phosphate group,  the CoI 5’ AUG and CoI AUG68 mRNAs were 
phosphorylated using polynucleotide kinase and then tested for activity in initiation 
complex formation.  The mitochondrial ribosome showed the same discrimination between 
the 5’ AUG and the AUG68 mRNAs, regardless of the presence of a 5’-OH or a 5’ phosphate 
(Figure 3-6), suggesting that the presence of a 5’ phosphate on the mRNAs does not affect 
the preferential use of the 5’ AUG codon. 
 
Competition Between the AUG68 mRNA and the 5’ AUG mRNA 
 It is known that mitochondrial mRNAs bind to the 28S subunit in a sequence 
independent manner 
(13).  A model of this 
binding could be that 
the 28S subunit binds 
the mRNA at the 
mRNA entrance gate, 
and in the absence of 
a 5’ AUG start codon 
to trap fMet-tRNA and 
stabilize initiation 
complex formation, 
the mRNA continues 
to slide through the 
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gate and eventually exits the small subunit.  If that model is correct, it is expected that the 
AUG68 mRNA would be capable of binding the SSU in a transient fashion and could, thus, 
compete with initiation complex formation on the 5’ AUG mRNA.  To test this idea, 
increasing amounts of AUG68 mRNA were added to initiation complex formation assays 
using the 5’ AUG mRNA.  As indicated in Figure 3-7, addition of the AUG68 mRNA led to an 
inhibition of [35S]fMet-tRNA binding to 55S ribosomes in response to the 5’ AUG mRNA.  
This data suggests that the AUG68 mRNA is able to bind ribosomes, but fails to form a stable 
initiation complex due to the lack of the 5’ start codon.  This model is consistent with the 
weak toeprint signal on the AUG68 mRNA at nucleotide 17.  The high levels of the AUG68 
mRNA required to compete with the 5’ AUG mRNA for ribosome binding indicate that the 
binding of mRNAs that lack a 5’ AUG is not stable, possibly due to a decrease in the koff.  In 
contrast, the presence of fMet-tRNA on a 5’ AUG codon strengthens the initiation complex 
on the ribosome, leading to a very stable complex. 
 
Effect of Additional Nucleotides 5’ to the AUG on Initiation Complex Formation 
 In human mitochondrial mRNAs, the maximum number of nucleotides preceeding a 
start codon is three, as observed in CoI mRNA (2).  In the case of the AUG68 mRNA, where 
the start codon is located 68 nucleotides into the mRNA, no initiation complexes were 
formed on 55S ribosomes.  Since 68 nucleotides prior to the AUG codon are prohibitive to 
initiation complex formation, it was interesting to examine exactly how many nucleotides 
prior to the 5’ AUG could be tolerated.  A series of 5’ extended mRNAs were prepared 
containing 1, 2, 3, 6, 9, and 12 nucleotides prior to the 5’ AUG (Figure 3-1).  The nucleotides 
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Figure 3-8.  Effect of the addition of nucleotides 5’ to the 
AUG start codon on initiation complex formation on 
mitochondrial 55S ribosomes.  [35S]fMet-tRNA binding to 
mitochondrial 55S ribosomes was tested in the presence of 
increasing amounts of 5’ extended mRNAs.   The mRNA was 
limiting in this assay, giving 0.1 pmol fMet-tRNA bound for 
the 5’ AUG mRNA.  This value was set as 100% initiation 
complex formation, and the values obtained for the other 
mRNAs are plotted as a % of this mRNA. 
added correspond to the 12 nucleotides present in the human mitochondrial genome 
between the upstream cistron and the start codon of the CoI mRNA.  Three of these are 
present in the mature mRNA (2).  As indicated in Figure 3-8, initiation complex formation 
was slightly reduced by 
the addition of a single 
nucleotide prior to the 5’ 
AUG.  The presence of 
only 3 nucleotides 
preceeding the AUG 
codon lead to a steeper 
decrease in initiation 
complex formation 
(>40%).  The presence of 
additional nucleotides 
prior to the AUG start 
codon led to further 
decreases in initiation 
complex formation, with 80% inhibition of initiation complex formation observed when 12 
additional nucleotides were present 5’ to the start codon.  This result indicates that the 
ribosome is less efficient in recognizing the start codon of mRNAs with more than 3 
nucleotides 5’ to the AUG. 
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Figure 3-9.  Initiation complex formation on 
mitochondrial 55S ribosomes using ND2 mRNAs.  
[35S]fMet-tRNA binding to mitochondrial 55S particles 
was tested in the presence of increasing amounts of ND2 
5’ AUG, AUG91, or 0 AUG mRNA.  A blank (~0.08 pmol) 
corresponding to the amount of fMet-tRNA bound to 55S 
ribosomes in the absence of mRNA was subtracted from 
each value. 
Preferential Selection of the 5’ AUG is Observed on Additional Mitochondrial mRNAs 
 All assays performed above used CoI mRNA.  To ensure that the results obtained 
were applicable to other mRNAs, a second mRNA, derived from the first 150 nucleotides of 
ND2, was tested in initiation complex formation.  In mammalian mitochondria, both AUG 
and AUA serve as Met codons.  The ND2 mRNA uses an AUA start codon.  Since yeast 
[35S]fMet-tRNA was used in the initiation complex formation assays performed here, and 
AUA is not recognized as a 
start codon in the yeast 
translation system, the AUA 
start codon present in ND2 
was changed to AUG.  
Variations of the ND2 mRNA 
with the 5’ AUG, with an 
AUG at position 91, or 
lacking AUG codons (Figure 
3-1) were tested in initiation 
complex formation.  The 
same preferential use of a 5’ 
start codon by 55S 
ribosomes was observed with these mRNAs (Figure 3-9).  The ND2 mRNA with the 5’ AUG 
readily formed initiation complexes.  However, no initiation complexes were formed using 
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Figure 3-10.  Initiation complex formation on mitochondrial 
55S ribosomes using tRNAMet/ND2 mRNAs.  [35S]fMet-tRNA 
binding to mitochondrial 55S particles was tested in the 
presence of increasing amounts of ND2 5’ AUG and 
tRNAMet/ND2 mRNAs.  A blank (~0.08 pmol) corresponding 
to the amount of fMet-tRNA bound to 55S ribosomes in the 
absence of mRNA was subtracted from each value. 
the ND2 AUG91 mRNA or 0 AUG mRNA.  This observation suggests that ribosomal 
discrimination in favor of a 5’ AUG is a general phenomenon for all mitochondrial mRNAs. 
 
Efficient Initiation Complex Formation Requires Post-Transcriptional mRNA Processing 
 Both strands of mitochondrial DNA are transcribed into long polycistronic RNAs (24).  
In many cases, tRNAs exist between protein-coding regions and fold into defined structural 
elements where they serve as processing signals (25).  For example, the ND2 coding region 
is preceded by the upstream tRNAMet gene.  It is generally assumed that processing to 
remove the upstream sequence must occur prior to the use of the mRNAs in translation.  To 
test whether the tRNA 
gene impairs initiation 
complex formation, we 
compared initiation 
complex formation of the 
ND2 mRNA and a 
derivative of the mRNA 
carrying the upstream 
tRNAMet (Figure 3-10).  In 
both cases, AUG was used 
as the start codon in place 
of AUA.  Both mRNAs were 
prepared by hammerhead 
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cleavage to ensure that they were treated identically.  As expected, very few initiation 
complexes were formed on the tRNAMet/ND2 mRNA (Figure 3-10), indicating that translation 
of ND2 prior to cleavage of tRNAMet from its 5’ end is inefficient and most likely does not 
occur.  
 
 
DISCUSSION 
 
 Eukaryotic ribosomes bind to mRNA in a cap-dependent manner and scan to find the 
first initiation codon (26).  Prokaryotic ribosomes find the AUG start codon with the help of 
SD/ASD interactions.  In this paper, we demonstrated that mitochondrial ribosomes 
recognize and bind to the start codon at the 5’ end of mitochondrial mRNAs using 
codon/anticodon interactions between the fMet-tRNA and the mRNA.  These interactions 
are strengthened by the addition of IF2mt, which agrees with the previous proposed role of 
IF2mt in promoting the binding of fMet-tRNA to the ribosome.   
 The sequences of many mitochondrial genomes are known.  DNA sequence analysis 
reveals that few or no nucleotides exist prior to the start codon in animals.  Of the 13 
proteins coded for by bovine mitochondrial DNA, about half contain noncoding nucleotides 
prior to the start codon.  The highest number of noncoding nucleotides between genes in 
this organism is four (Table 3-5).  No in vivo analysis of the 5’ ends of the mRNA has been 
done in the bovine system.  In human mitochondrial DNA, up to 12 nucleotides exist prior to 
the 5’ start codon of five different genes (the rest lack 5’ untranslated nucleotides), but 
direct analysis of the mRNAs demonstrated that post-transcriptional processing eliminates 
the 5’ leader in all but three mRNAs (2).  In contrast to these organisms, all noncoding 
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nucleotides in Drosophila melanogaster mitochondrial mRNAs are post-transcriptionally 
cleaved prior to translation, which indicates that the presence of any nucleotides before the 
start codon may be inhibitory for translational initiation (27).   While mRNAs with few or no 
nucleotides prior to the 5’ start codon are common in mitochondria, there seems to be no 
consistency in which genes have noncoding nucleotides and how many nucleotides are 
present. 
 
 
Table 3-5.  Summary of nucleotides 5’ to the AUG start codon in Bos taurus, Homo sapiens, 
and Drosophila melanogaster mitochondrial mRNAs.1 
 
Protein 
Sequence 
5’ to 
protein 
Bos taurus 
DNA 
sequence2 
Homo 
sapiens 
DNA 
sequence2 
Homo 
sapiens 
mRNA 
Drosophila 
melanogaster 
DNA sequence 
Drosophila 
melanogaster 
mRNA 
sequence 
NADH Dehydrogenase 
ND1 
tRNALeu   
→3 
AAATG ACATA ACAUA CTTG UUG 
ND2 
tRNAMet  
→ 
ATA ATT AUU ATT AUU 
ND3 
tRNAGly  
→ 
ATA ATA AUA ATT AUU 
ND4 
Overlaps 
with 
ND4L 
ATG ATG AUG --- --- 
ND4L 
tRNAArg  
→ 
ATG ATG AUG AATG AUG 
ND5 
tRNALeu  
→ 
ATA ATA AUA ATG AUG 
ND6 
←  
tRNAGlu 
ATG ATG AUG AATT AUU 
                                                             
1Sequence data obtained from (2;27-29). 
2
Between upstream gene and start codon. 
3
The forward arrow indicates that the upstream gene is on the same strand as the mRNA coding sequence 
while the backward arrow indicates that the coding sequence for the upstream gene is on the opposite strand 
as the mRNA. 
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Coenzyme Q – Cytochrome C Reductase 
Cyt. B 
←  
tRNAGlu 
ACTAATG ACCAATG AUG ATG AUG 
Cytochrome C Oxidase 
CoI 
←  
tRNATyr 
CATG 
TCACCGC
CACTGAT
G 
CTGAUG ATCG UCG 
CoII 
tRNAAsp  
→ 
TATG ATG AUG TAAATG AUG 
CoIII ATP6  → TAATG TAATG AUG ATG AUG 
ATP Synthase 
ATP6 
Overlaps 
with 
ATP8 → 
ATG ATG AUG --- --- 
ATP8 
tRNALys  
→ 
CATG AATG AAUG ATT AUU 
 
 The mechanism of post-transcriptional processing in mitochondria has been 
proposed as a “tRNA punctuation” model.  It is known that mitochondrial DNA is 
transcribed as a long polycistronic mRNA.  The tRNA punctuation model predicts that tRNAs 
are removed from the transcript via post-transcriptional cleavage, and mature mRNAs 
remain that are ready for translation (25).  This model accurately predicts nucleotides 5’ to 
the start codon for mRNAs with tRNAs immediately preceding them in human 
mitochondrial DNA.  One example where the tRNA punctuation model does not apply is in 
the case of the gene coding for CoIII, which is preceded by the gene coding for ATP6 instead 
of a tRNA.  Thus, cleavage of CoIII requires a mechanism distinct from tRNA recognition. In 
this paper, we clearly demonstrate that post-transcriptional processing in bovine 
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mitochondria is necessary prior to translation, since initiation of mRNAs containing more 
than 3-6 nucleotides prior to the 5’ AUG is very inefficient. 
 In prokaryotes, it is known that transcription and translation can occur 
simultaneously.  Therefore, it was of interest to determine whether the mitochondrial 
system, proposed to be derived from a prokaryotic ancestor, operates in the same manner.  
It is obvious that, since mitochondrial mRNAs do not contain SD sequences in their mRNAs, 
they must initiate protein synthesis using a mechanism distinct from the prokaryotic 
system.  This paper demonstrated that mitochondrial 55S ribosomes were unable to initiate 
on an ND2 mRNA that was still attached to the tRNAMet on its 5’ end, indicating that post-
transcriptional processing to remove tRNAs must occur prior to translation in mammalian 
mitochondria. 
Our current model for initiation in mammalian mitochondria is illustrated in Figure 
3-11.  IF3mt first interacts with the 55S ribosome, forming a transient 28S:IF3mt:39S 
intermediate complex (step 1) (30). This transient complex dissociates into free 28S 
subunits bound to IF3mt and free 39S subunits (Figure 3-11, step 2).  Following the ribosome 
dissociation step, the mRNA feeds into the mRNA entrance tunnel on the 28S subunit 
(Figure 3-11, step 3).  It is unclear whether IF2mt:GTP binds at this point or later.  It is 
believed that mRNA binding precedes fMet-tRNA binding, because IF3mt has been shown to 
destabilize the fMet-tRNA bound to 28S subunits in the absence of mRNA (12).  When the 
first 17 nucleotides have entered the ribosome, the ribosome pauses and inspects the 
codon at the 5’ end of the mRNA, giving rise to the weak toeprint at position 17 relative to 
the 5’ end regardless of the presence or absence of a 5’ AUG codon.  During this pause, 
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Figure 3-11.  Model for the initiation of mammalian mitochondrial protein synthesis. 
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IF2mt:GTP promotes the binding of fMet-tRNA to the ribosome (Figure 3-11, step 4) and 
codon:anticodon interactions between the fMet-tRNA and the AUG start codon promote 
the formation of a stable initiation complex (Figure 3-11, step 4).  The formation of this 
complex leads to the strong toeprint at positions 17-19.  If no codon/anticodon interactions 
occur due to a lack of fMet-tRNA and/or the absence of a 5’ AUG start codon, the mRNA 
resumes sliding through the ribosome and eventually dissociates.  This idea explains the lack 
of a toeprint signal at position 18, 19, or 85 on the AUG68 mRNA.  If fMet-tRNA binds to the 
5’ start codon, the large subunit binds, IF2mt hydrolyzes GTP to GDP, and the initiation 
factors leave, resulting in a full 55S initiation complex that is then free to move to the 
elongation phase of protein synthesis (Figure 3-11, step 5). 
In future work, it will be particularly interesting to determine what creates the pause 
as the mRNA is fed into the P-site.  This pause creates a kinetic opportunity for the selection 
of a 5’ start codon by the binding of the initiator tRNA to the P-site.  
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CHAPTER 4 
 
ANALYSIS OF THE FUNCTIONAL CONSEQUENCES OF LETHAL MUTATIONS IN 
MITOCHONDRIAL TRANSLATIONAL ELONGATION FACTORS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work from this chapter was done in collaboration with Kenta Akama, Christie Jones, and 
Nono Takeuchi, and is in preparation to be submitted for publication.
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INTRODUCTION 
During protein biosynthesis, elongation factor Tu (EF-Tu) forms a ternary complex 
with aa-tRNA and GTP and promotes the binding of the aa-tRNA to the A-site of the 
ribosome (1).  Following codon:anticodon interactions, an EF-Tu:GDP complex is released 
from the ribosome.  Elongation factor Ts (EF-Ts) binds to the EF-Tu:GDP complex and 
promotes the exchange of GDP for GTP, regenerating the active EF-Tu:GTP complex (2). 
Mammalian mitochondria have a specific protein biosynthetic system responsible 
for the synthesis of thirteen polypeptides of the respiratory chain complexes.  Protein 
synthesis in this organelle requires elongation factors that correspond to EF-Tu and EF-Ts 
(EF-Tumt and EF-Tsmt).  Both of these proteins are encoded in the nuclear genome, 
synthesized in the cell cytoplasm, and subsequently imported into the mitochondrion.  
While mutations in mitochondrial DNA are well known to cause disease, few mutations 
have been identified in nuclear genes that encode mitochondrial proteins required for 
protein biosynthesis in this organelle. Recently, a mutation in the gene coding for EF-Tsmt 
(Arg312 to Trp)1 was reported leading to encephalomyopathy in one patient and 
hypertrophic cardiomyopathy in another (3).  Both patients died at 7 weeks of age.  This 
mutation is predicted to disrupt important interactions between EF-Tumt and EF-Tsmt.  
EF-Tsmt is a 30.7 kDa protein that consists of an N-terminal domain and a core 
domain divided into N- and C-terminal subdomains (Figure 4-1) (4).  EF-Tumt and EF-Tsmt 
                                                             
1In the original paper (3), the position identified as mutated is listed as Arg333.  This position corresponds to 
the residue in isoform 2 of human EF-Tsmt (P-43897-2).  However, there is no direct experimental evidence for 
the expression of this isoform.  Rather, isoform 1 (P-43897-1) has been chosen as the canonical sequence.  In 
humans, the mutation in isoform 1 is in position 312 (R312W).  There is direct experimental evidence for 
isoform 1 in the bovine system.  The mutation created here is in isoform 1 of Bos taurus EF-Tsmt and 
corresponds to residue 325 (R325W).  The mature forms of human and Bos taurus EF-Tsmt are over 92% 
identical. 
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Figure 4-1.  Structural view of the interaction of EF-Tumt with EF-Tsmt.  Overall 
structure of the EF-Tumt:EF-Tsmt complex (PDB 1XB2).  EF-Tumt is shown in red, and EF-
Tsmt is shown in green.  EF-Tsmt R325W is highlighted in blue, and EF-Tumt R336Q is 
highlighted in yellow. 
Domain I
Domain II
Domain III
N-domain
Core
Subdomain N
Subdomain C
EF-Tumt EF-Tsmt
interact through extensive surface contacts.  The N-terminal domain and the subdomain N 
of the core of EF-Tsmt interact directly with the G-domain (domain I) of EF-Tumt, while the 
subdomain C of the core contacts domain III of EF-Tumt. 
Arg325 of EF-Tsmt is highly conserved and is found in most bacterial and 
mitochondrial factors (3). This residue is located in a β-strand in subdomain C of the core 
and is shown in blue in Figure 4-1 and Figure 4-2. While it does not make direct contact with 
EF-Tumt, other nearby residues in this region do.  Molecular modeling has predicted that the 
R325W mutation could disrupt the tertiary structure of the subdomain C of the core, 
altering its interactions with domain III of EF-Tumt (3).   Mutations in this region have been 
shown to reduce the affinity of EF-Tsmt for EF-Tumt about six to seven-fold (5). For example, 
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Figure 4-2.  Close-up view of the interaction of residues 
near the R325W mutation.  Domain III of EF-Tumt is 
shown in red, subdomain C of EF-Tsmt is shown in green, 
and EF-Tsmt R325W is shown in blue.  Residues known to 
be important for the interaction of EF-Tsmt with EF-Tumt 
are shown as purple (H231) and orange (L302 and L303) 
sticks. 
mutation of His231 (shown in purple in Figure 4-2) to Ala caused a 6-fold decrease in the 
binding constant governing the interaction of EF-Tsmt with EF-Tumt.  Mutation of L302 and 
L303 (shown in orange) caused a 7-fold decrease in the EF-Tumt:EF-Tsmt binding constant.  
We have directly examined 
the effect of the R325W 
mutation by testing the 
ability of this mutated 
protein to bind directly to 
EF-Tumt and to stimulate its 
activity in poly(U)-directed 
polymerization.  
 EF-Tumt is a 45.1 kDa 
protein composed of three 
domains. Domain I contains 
the guanine nucleotide 
binding site. All three domains are involved in binding the aa-tRNA (6), while domains I and 
III interact with EF-Tsmt. The stable binding of guanine nucleotides and EF-Tsmt to EF-Tumt are 
mutually exclusive, allowing EF-Tsmt to serve as a nucleotide exchange factor for EF-Tumt 
(7;8).  
 A mutation in EF-Tumt, (Arg336 to Gln), was discovered in an infant with lactic 
acidosis and fetal encephalopathy (9).  The infant later died at an age of 14 months.  Arg336 
of EF-Tumt is located in domain II of the protein, in a region known to interact with the 
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acceptor stem of the aa-tRNAs (Figure 4-1).  EF-Tumt R336Q was previously found to be 
unable to form a ternary complex with mitochondrial Ser-tRNA (10). The mutated factor 
was also deficient in poly(U)-directed poly(Phe) synthesis using mitochondrial Phe-tRNA and 
E. coli 70S ribosomes.  However, no studies were carried out with mitochondrial ribosomes 
and mitochondrial elongation factor G (EF-G1mt) (10).   In this study, the activity of the 
mutated EF-Tumt has been examined on mitochondrial ribosomes, and the effect of the 
mutation on its ability to form ternary complexes with several additional mitochondrial aa-
tRNAs has been examined.  
 
MATERIALS AND METHODS 
Materials 
[14C]phenylalanine and [35S]methionine were purchased from Perkin Elmer Life 
Sciences, Inc.  E. coli tRNA was obtained from Boehringer Mannheim.  E. coli [14C]Phe-tRNA  
and the human mitochondrial [35S]Met-tRNA transcript were prepared as described (11;12).  
Mitochondrial tRNA was purified from bovine mitoplasts using the Qiagen RNA/DNA maxi 
kit.  The tRNAPhe was aminoacylated using [14C]Phe as described (13).  E. coli ribosomes 
were purified from E. coli W cells; mitochondrial 55S ribosomes, and EF-G1mt were purified 
as described (14;15). 
 
Cloning, Expression, and Purification of Proteins 
BMtu/pET24c and BMts/pET24c, the E. coli expression vectors for C-terminal 
histidine-tagged bovine EF-Tumt and EF-Tsmt, are described in (16;17) and the proteins 
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expressed from them are referred to as the wild-type (WT) proteins. Expression vectors for 
the mutant EF-Tumt (R336Q) and mutant EF-Tsmt (R325W) were constructed by using the 
Quik Change site-directed mutagenesis kit (Stratagene).  EF-Tumt and EF-Tsmt were purified 
using described protocols (4;16;18). 
 
Circular Dichroism of EF-Tsmt and EF-Tsmt R325W 
 Purified EF-Tsmt and EF-Tsmt R325W were dialyzed in 1000 volumes CD buffer 
containing: 10 mM MgSO4, 50 mM potassium phosphate buffer (pH 7.6), and 5% glycerol for 
4 h with a change of buffer after 2 h.  CD spectra of EF-Tsmt and EF-Tsmt R325W were 
obtained using an Aviv Model 62DS CD Spectrometer.  Data points were collected in 1 nm 
steps, and data was analyzed using the CD Pro software. 
 
Poly(Phe) Polymerization Assays 
To test the ability of EF-Tsmt to stimulate the the activity of EF-Tumt in poly(Phe) 
directed polymerization, reaction mixtures (25 µL) contained 50 mM Tris-HCl (pH 7.8), 1 mM 
DTT, 0.1 mM spermine, 6 mM MgCl2, 80 mM KCl, 0.5 mM GTP, 1.25mM PEP, 0.4 U pyruvate 
kinase, 3 µg poly(U) mRNA, 8.3 pmol (0.33 µM) E. coli [14C]Phe-tRNA, 5 pmol (0.2 µM) EF-
G1mt, 0.25 µM E. coli 70S ribosomes, 0.5 pmol (20 nM) EF-Tumt, and 0.025-0.075 pmol (1-3 
nM) EF-Tsmt.  The reaction mixtures were incubated at 37 °C for 30 min and analyzed as 
described (19).  A blank representing the amount of label retained on the filter in the 
absence of EF-Tsmt was not subtracted. 
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To test the poly(Phe) polymerization activity of WT and mutated EF-Tumt in the E. 
coli system, reaction mixtures (25 µL) contained 50 mM Tris-HCl (pH 7.8), 1 mM DTT, 0.1 
mM spermine, 6 mM MgCl2, 80 mM KCl, 0.5 mM GTP, 1.25 mM PEP, 0.4 U pyruvate kinase, 
3 µg poly(U), 8.3 pmol (0.3 µM) E. coli [14C]Phe-tRNA, 5 pmol (0.2 µM) EF-G1mt, 16 µg (0.25 
µM) E. coli 70S ribosomes, and 0.2-0.8 pmol (8-32 nM) EF-Tumt (WT or R336Q) in a 1:1 mix 
with EF-Tsmt. Reaction mixtures were incubated at 37 °C for 30 min, at which time they were 
quenched by the addition of 5% TCA and processed as described (19).  A blank representing 
the amount of label retained on the filter in the absence of EF-Tumt (~0.3 pmol) was 
subtracted from each value. 
For assays performed in the mitochondrial system, the reaction mixtures (25 µL) 
contained 50 mM Tris-HCl (pH 7.8), 1 mM DTT, 0.1 mM spermine, 7.5 mM MgCl2, 40 mM 
KCl, 0.5 mM GTP, 1.25 mM PEP, 0.4 U pyruvate kinase, 3 µg poly(U), 3 pmol (0.12 µM) 
mitochondrial [14C]Phe-tRNA, 5 pmol (0.2 µM) EF-G1mt, 3 pmol (0.12 µM) mitochondrial 55S 
ribosomes, and 0.2-0.8 pmol EF-Tumt (WT or the R336Q mutated protein) in a 1:1 mixture 
with EF-Tsmt. Reactions were incubated at 37 °C for 30 min, quenched by the addition of 5% 
TCA, and processed as described (19).  A blank representing the amount of label retained on 
the filter in the absence of EF-Tumt (~0.08 pmol) was subtracted from each value. 
 
Physical Interaction of EF-Tumt and EF-Tsmt Measured Using a Gel-Shift Assay 
The binding of EF-Tsmt to EF-Tumt was studied using a gel-shift assay according to 
(20). Briefly, EF-Tsmt:GDP (40 pmol) and EF-Tumt (0-40 pmol) were incubated on ice for 5 min 
in a reaction mixture (10 µL) containing 50 mM Tris-HCl (pH 7.5), 70 mM KCl, 1.5 mM EDTA, 
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10% glycerol, 1 mM DTT, 0.004% bromophenol blue. The samples were resolved by native 
polyacrylamide gel electrophoresis (PAGE). The electrophoresis was performed at 4°C (450 
V, 2 h) on a 1 mm x 20 cm x 10 cm 9% PAGE gel (acrylamide:bisacrylamide 29:1) containing 
8 mM Tricine-NaOH (pH 8.2), 1 mM EDTA and 5% glycerol. The running buffer contained  8 
mM Tricine-NaOH (pH 8.2) and 1 mM EDTA. The proteins were visualized using SYPRO Ruby 
(Molecular Probes). 
 
Ternary Complex Formation Measured Using Hydrolysis Protection 
The ability of EF-Tumt and EF-Tumt R336Q to protect aa-tRNA from spontaneous 
deacylation was monitored as described (20), with slight modifications. Ternary complexes 
were formed in reaction mixtures (100 µL) containing 75 mM Tris-HCl (pH 7.5), 75 mM 
NH4Cl, 15 mM MgCl2, 7.5 mM DTT, 60 µg/mL BSA, 1 mM GTP, 2.4 mM PEP, 0.1 mU pyruvate 
kinase, 12.5 pmol (0.125 µM) E. coli [14C]Phe-tRNA, and 0-330 pmol (0-3.3 µM) EF-Tumt (WT 
or R336Q).  The samples were incubated for the indicated times at 30 °C, and precipitated in 
cold 5% TCA.  The remaining aa-tRNA was collected on filter papers (3MM, Whatman) and 
the amount of EF-Tu:GTP:[14C]Phe-tRNA was quantified using a liquid scintillation counter.  
 
Ternary Complex Formation Measured Using RNase Protection 
Ternary complex formation assays were carried out in reaction mixtures (50 µL) 
containing 20 mM HEPES-KOH (pH 7.0), 1 mM DTT, 6.7 mM MgCl2, 68 mM KCl, 0.5 mM GTP, 
1.25 mM PEP, 0.8 U pyruvate kinase, 7.2 pmol (0.14 µM) E. coli [14C]Phe-tRNA, and 0-20 
pmol (0.1-0.4 µM) EF-Tumt (WT or R336Q).  For experiments using mitochondrial tRNAs, 5.3 
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Figure 4-3.  Circular dichroism spectra of EF-Tsmt and EF-Tsmt 
R325W.  CD spectra of EF-Tsmt (WT and R325W) obtained as 
described in Materials and Methods. 
pmol (0.11 µM) native bovine mitochondrial [14C]Phe-tRNA or 9.6 pmol (0.19 µM) of the 
human mitochondrial [35S]Met-tRNA transcript and 0-60 pmol (0.3-1.2 µM) EF-Tumt (WT or 
R336Q) were used.  The reactions were incubated for 15 min at 0 °C, at which time 10 µg 
RNase A was allowed to digest the sample for 30 s.  Ice cold 5% TCA was added, and the 
remaining aa-tRNA was precipitated at 0 °C for 10 min and analyzed as described (12;21).  A 
blank representing the amount of label retained on the filters in the absence of EF-Tumt 
(~0.3 pmol using E. coli [14C]Phe-tRNA, ~0.1 pmol using mitochondrial [14C]Phe-tRNA and 
~0.2 pmol using [35S]Met-tRNA) was subtracted from each value. 
 
RESULTS AND DISCUSSION 
Biochemical Consequences of the R325W Mutation in EF-Tsmt 
A mutated derivative of EF-Tsmt, corresponding to the lethal R325W mutation in 
humans, was prepared 
using site-directed 
mutagenesis (3).  To 
determine whether the 
mutation adversely 
affected the structure 
of EF-Tsmt, the CD 
spectra of the mutated 
derivative was 
compared to that of the 
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Figure 4-4.  Activity of EF-Tsmt and EF-Tsmt R325W in poly(Phe) 
polymerization.  The abilities of EF-Tsmt and EF-Tsmt R325W to 
function in a poly(U)-directed peptide polymerization assay 
were tested using EF-Tumt and E. coli [
14C]Phe-tRNA.  EF-Tsmt is 
shown in closed squares and EF-Tsmt R325W is shown in closed 
circles.  The assays were performed multiple times and data 
were normalized with respect to the point containing 0.05 pmol 
of EF-Tsmt. 
WT factor.  As indicated in Figure 4-3, the α-helical content of the mutated protein did not 
change significantly with respect to the wild-type factor, suggesting that the protein 
retained its normal secondary structure.  A thermal melt monitored by CD indicated that 
both EF-Tsmt and EF-Tsmt R325W unfold at the same temperature (data not shown), 
indicating that the mutation has not greatly destabilized the protein.    
To investigate the biochemical effect of the R325W mutation, the ability of EF-Tsmt 
and its R325W variant to stimulate the activity of EF-Tumt in poly(Phe) polymerization was 
examined.  EF-Tumt alone has measurable activity in polymerization (Figure 4-4). However, 
its activity is 
enhanced by the 
presence of EF-Tsmt 
due to an increase in 
the guanine 
nucleotide exchange 
rate, allowing EF-Tumt 
to operate with a 
higher turnover 
number.  Wild-type 
EF-Tsmt stimulated 
the activity of EF-Tumt 
more than 2-fold 
under the reaction 
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Figure 4-5.  Physical interaction of EF-Tsmt and EF-Tsmt R325W with 
EF-Tumt.  The abilities of EF-Tsmt and EF-Tsmt R325W to bind to EF-
Tumt were measured using a gel shift assay on native PAGE.  WT EF-
Tsmt (upper panel) or EF-Tsmt R325W (lower panel) were incubated 
with the indicated amount of EF-Tumt. The proteins were separated 
on native-PAGE and visualized by SYPRO Ruby. The position of EF-
Tsmt, EF-Tumt:EF-Tsmt complex and EF-Tumt are indicated with 
arrows.  Data and figure provided by K. Akama and N. Takeuchi. 
conditions used (Figure 4-4). This value is consistent with previous observations (22). 
However, the stimulation of EF-Tumt by the R325W variant was reduced substantially, and 
only a 1.2-fold stimulation was observed (Figure 4-4).  This reduction could arise from the 
failure of the mutated EF-Tsmt to interact with EF-Tumt:GDP effectively, reducing GDP 
release and formation of an EF-Tumt:EF-Tsmt complex.  The reduction could also reflect a 
failure of the EF-Tumt:EF-Tsmt complex to bind GTP, which is necessary to release EF-Tumt for 
another round of polymerization.  
To investigate the interaction between EF-Tumt and EF-Tsmt R325W directly, the 
binding of the two proteins was studied using a gel-shift assay (Figure 4-5). EF-Tsmt or EF-
Tsmt R325W was incubated with increasing amounts of EF-Tumt. After complex formation, 
the proteins were separated on native-PAGE.  This gel system separates EF-Tsmt from the 
EF-Tumt:EF-Tsmt 
complex.  
However, the 
mobility of EF-
Tumt:EF-Tsmt 
complex was quite 
similar to that for 
EF-Tumt, and the 
resolution of the 
complex from free 
EF-Tumt was 
R325W 
WT 
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Figure 4-6.  Efficiency of the complex formation in Figure 4-
5 assessed by quantitating the amount of free EF-Tsmt 
remaining.  The relative amount of free EF-Tsmt in each 
panel was normalized to a value of 1 for EF-Tsmt. EF-Tsmt is 
shown in closed circles, and EF-Tsmt R325W is shown in 
closed squares.  Data for figure provided by K. Akama and 
N. Takeuchi. 
difficult. Thus, the efficiency of complex formation was assessed by the quantity of free EF-
Tsmt remaining.  Wild-type EF-Tsmt was effective in forming a complex with EF-Tumt in a dose 
dependent manner. Approximately 60% of EF-Tsmt bound EF-Tumt when incubation was 
carried out using equal molar amounts of the two factors (Figure 4-5, upper and Figure 4-6, 
closed circles). In contrast, EF-Tsmt R325W was ineffective in binding EF-Tumt and remained 
free, even when incubated with an equal amount of EF-Tumt (Figure 4-5, lower and Figure 4-
6, closed squares). These results indicate that the reduction in poly(U)-dependent poly(Phe) 
synthesis with the mutated EF-Tsmt arises to a large extent from a failure of the mutated EF-
Tsmt to interact with EF-Tumt.   
This effect 
observed with the R325W 
mutation is in agreement 
with previous mutational 
data as described in the 
introduction (9).  The data 
provided here and the 
mutational studies carried 
out previously indicate 
that the interactions of 
residues in the β-sheet of 
subdomain C and other 
nearby residues with EF-Tumt are essential for the stable binding of EF-Tumt with EF-Tsmt. 
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Biochemical Consequences of the R336Q Mutation in EF-Tumt 
Previous work on the lethal R336Q mutation in EF-Tumt indicated that this mutation 
did not affect the structural integrity of EF-Tumt, as demonstrated by CD spectroscopy (10). 
However, the mutation drastically reduced the ability of EF-Tumt to promote polymerization 
using mitochondrial [14C]Phe-tRNA on E. coli ribosomes (10).  The R336Q mutation was not 
predicted to influence the interaction of EF-Tumt with EF-Tsmt, because the primary 
interaction with EF-Tsmt occurs via interactions involving domains I and III (4).  The mutation 
was also not expected to interfere with GTP binding, which is localized to domain I.  Further, 
previous data indicated that Glu287 in E. coli (corresponding to Arg335 in EF-Tumt), the 
residue adjacent to Arg336, did not affect GTP binding (21).  Mutation of Arg335 to glutamic 
acid did result in reduced activity of EF-Tumt in both ternary complex formation and A-site 
binding with mitochondrial Phe-tRNAPhe. 
The effects of the R336Q mutation on the activity of EF-Tumt were examined further 
using E. coli and mitochondrial ribosomes and aa-tRNAs. Surprisingly, when EF-Tumt R336Q 
was tested in poly(U)-directed polymerization using E. coli [14C]Phe-tRNA and E. coli 70S 
ribosomes, it was as active as the wild-type factor in this assay (Figure 4-7).  However, in the 
homologous system using mitochondrial [14C]Phe-tRNA and ribosomes, EF-Tumt R336Q was 
almost inactive in polypeptide chain elongation (Figure 4-8).  Previous work (10) indicated 
that EF-Tumt R336Q lacked activity with mitochondrial Phe-tRNA when tested on E. coli 
ribosomes, suggesting that the lack of activity in the mitochondrial system was not a 
function of the ribosomes used but, rather, due to a failure of the mutated factor to interact 
with mitochondrial Phe-tRNA. Mitochondrial tRNAs are less structurally stable than E. coli 
105 
 
EF-Tu (pmol)
0.0 0.1 0.2 0.3 0.4 0.5
[1
4
C
]P
h
e
 p
o
ly
m
e
ri
z
e
d
 (
p
m
o
l)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
EF-Tu
EF-Tu R336Q
Figure 4-7.  Poly(Phe) polymerization with EF-Tumt and 
EF-Tumt R336Q using E. coli 70S ribosomes and E. coli 
[14C]Phe-tRNA.  The abilities of EF-Tumt and its R336Q 
derivative to function in a poly(Phe) polymerization 
assay was tested as described in Materials and 
Methods.  EF-Tumt is shown in closed circles and EF-Tumt 
R336Q in closed squares.   
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Figure 4-8.  Poly(Phe) polymerization with EF-Tumt and 
EF-Tumt R336Q using mitochondrial 55S ribosomes and 
native bovine mitochondrial [14C]Phe-tRNA.  The 
abilities of EF-Tumt and its R336Q derivative to function 
in a poly(Phe) polymerization assay was tested as 
described in Materials and Methods.  EF-Tumt is shown 
in closed circles and EF-Tumt R336Q is shown in closed 
squares. 
tRNAs (12), and additional 
stabilizing interactions 
between EF-Tumt and the 
mitochondrial aa-tRNA may 
be important in forming the 
ternary complex.  
 The poly(Phe) 
polymerization assay does not 
directly measure the 
interaction between EF-Tumt 
and aa-tRNA. This interaction 
can be measured directly 
using one of two ternary 
complex formation assays: 
the hydrolysis protection 
assay and the RNase 
protection assay. The 
hydrolysis protection assay 
measures the ability of EF-
Tumt to protect the aa-tRNA 
bond from spontaneous 
hydrolysis.  Since the mutated 
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Figure 4-9.  Activities of EF-Tumt and EF-Tumt R336Q in 
ternary complex formation measured using a non-
enzymatic hydrolysis protection assay.  Amount of 
[14C]Phe-tRNA protected from hydrolysis by increasing 
concentrations of EF-Tumt (solid lines) and EF-Tumt R336Q 
(dashed lines) as a function of time.  Data for figure 
provided by K. Akama and N. Takeuchi.  
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Figure 4-10.  Relative amount of [14C]Phe-tRNA at time 60 
min in Figure 4-9 plotted against the EF-Tumt 
concentration.  Data for figure provided by K. Akama and 
N. Takeuchi. 
EF-Tumt was active using E. 
coli Phe-tRNA in 
polymerization, its 
interaction with bacterial 
Phe-tRNA was tested 
directly.  The spontaneous 
hydrolysis of E. coli Phe-
tRNA was apparent (Figure 
4-9, closed circles).  When 
bound to EF-Tumt, the Phe-
tRNA bond was clearly 
protected from hydrolysis 
(Figure 4-9, solid lines).  
However, when the R336Q 
derivative of EF-Tumt was 
used in place of the normal 
factor, substantially less 
protection of the Phe-tRNA 
bond was observed (Figure 
4-9, dashed lines).  At 
sufficiently high 
concentrations of EF-Tumt 
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Figure 4-11.  Activities of EF-Tumt and EF-Tumt R336Q 
in ternary complex formation using E. coli [14C]Phe-
tRNA measured using an RNase protection assay.  EF-
Tumt is shown in closed circles and EF-Tumt R336Q is 
shown in closed squares.   
R336Q, considerable ternary complex is formed (Figure 4-10, closed squares), indicating 
that R336Q has some ability to bind E. coli Phe-tRNA.  This data suggests that, although the 
mutated protein is deficient in binding to E. coli Phe-tRNA, the reduced affinity is not 
sufficient to prevent its efficient use in polymerization (Figure 4-7). 
 To verify the results obtained from the hydrolysis protection experiments and to 
examine the interaction with mitochondrial aa-tRNAs, the RNase protection assay was used. 
This assay measures the ability of EF-Tumt to protect the acceptor stem of the aa-tRNA from 
degradation by RNase A.  Because the RNase A digestion of the tRNA is done in 30 s, it 
provides a snapshot of the interaction between the two molecules. When the binding of EF-
Tumt to E. coli [
14C]Phe-tRNA was tested, the R336Q variant showed a decrease in binding of 
just over 50% (Figure 4-11), 
indicating that the mutation 
reduces but does not abolish the 
ability of EF-Tumt to form a 
ternary complex with bacterial 
aa-tRNAs. These results agree 
with the observation above, that 
the reduction in ternary complex 
formation is not sufficient to 
compromise the activity of this 
factor in polymerization (Figure 
4-7). It is important to note that the binding of the aa-tRNA to EF-Tumt is probably not the 
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Figure 4-12.  Activities of EF-Tumt and EF-Tumt R336Q 
in ternary complex formation using native bovine 
mitochondrial [14C]Phe-tRNA measured using an 
RNase protection assay.  EF-Tumt is shown in closed 
circles and EF-Tumt R336Q is shown in closed squares. 
rate limiting step in polypeptide chain elongation.  Rather, interactions with the ribosome, 
including the release of inorganic phosphate from EF-Tumt following GTP hydrolysis, appear 
to be rate limiting (23).  
 Previous work indicated that EF-Tumt R336Q did not bind mitochondrial Ser-tRNA 
effectively in the ternary complex (10). This observation is in sharp contrast to the 
significant level of ternary complex formation observed with the E. coli Phe-tRNA (Figure 4-
11) but in agreement with the lack of polymerization observed with mitochondrial Phe-
tRNA (Figure 4-8). To explore 
whether the failure of EF-Tumt 
to use mitochondrial Phe-tRNA 
in polymerization arises from a 
failure of ternary complex 
formation, the RNase 
protection assay was carried 
out with mitochondrial 
[14C]Phe-tRNA (Figure 4-12).  EF-
Tumt was quite active in forming 
a ternary complex with native 
bovine mitochondrial Phe-tRNA. However, the R336Q variant did not bind mitochondrial 
Phe-tRNA detectably (Figure 4-12). This observation agrees with previous work and explains 
the lack of activity of the variant protein in poly(Phe)-directed polymerization with 
mitochondrial Phe-tRNA on mitochondrial 55S ribosomes (Figure 4-8). 
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Figure 4-13.  Activities of EF-Tumt and EF-Tumt R336Q 
in ternary complex formation using human 
mitochondrial [35S]Met-tRNA measured using an 
RNase protection assay.  EF-Tumt is shown in closed 
circles and EF-Tumt R336Q is shown in closed 
squares. 
To address the question of whether other mitochondrial aa-tRNAs also fail to bind 
the R336Q variant, ternary 
complex formation assays were 
carried out using human 
mitochondrial [35S]Met-tRNA 
(Figure 4-13).  This tRNA was 
transcribed in vitro and has been 
shown to properly fold and to 
bind EF-Tumt (12).  In this assay, 
EF-Tumt readily formed a ternary 
complex with mitochondrial 
[35S]Met-tRNA.  However, once 
again EF-Tumt R336Q was unable 
to bind mitochondrial [35S]Met-tRNA, indicating that the variant protein is unable to form 
ternary complexes with most or all mitochondrial aa-tRNAs. 
It is perplexing that the variant EF-Tumt can bind E. coli Phe-tRNA but not 
mitochondrial aa-tRNAs.  This discrepancy must stem from innate differences between the 
mitochondrial and bacterial tRNAs.  Canonical tRNAs fold into a distinct L-shape stabilized 
by strong G-C base pairs in the stems of the tRNA and tertiary interactions involving many 
invariant or semi-invariant residues (24). In contrast, mitochondrial tRNAs are characterized 
by weaker stems with numerous A-U base pairs or mismatches. They often lack the 
conserved residues that create important tertiary interactions in other tRNAs (25-27). 
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Although mitochondrial tRNAs can fold into an L-shape, the interactions that stabilize the 
elbow region are weaker (28).  Mitochondrial tRNAs observed on 55S ribosomes have an L-
shape but show a “caved in” feature at the corner of the L (28).  These unusual structural 
features of mitochondrial tRNAs may lead to a requirement for interactions with EF-Tumt 
that are not essential for the binding of canonical aa-tRNAs.   
Previous data indicate that mitochondrial aa-tRNAs must be phosphorylated at their 
5’ ends in order to bind effectively to EF-Tumt (12).  The crystal structure of the T. 
thermophilus ternary complex indicates that Arg300 (corresponding to Arg336 in EF-Tumt) 
forms a salt bridge with the phosphate group at the 5’ end of the aa-tRNA (Figure 4-14) (6).  
Replacement of the Arg with Gln in EF-Tumt could disrupt this interaction, since the side 
chain of Gln is shorter and may not be within bridging distance of the phosphate backbone.  
This interaction is not critical for the formation of the ternary complex with E. coli aa-tRNAs, 
in agreement with data showing that a 5’-phosphate is not important for ternary complex 
formation in prokaryotes (29).  However, the data presented here indicate that the 
interaction between Arg336 and the 5’ phosphate of mitochondrial aa-tRNAs is critical for 
ternary complex formation in the mitochondrial translational system. The interaction 
between Arg336 and the 5’ phosphate of aa-tRNAs could be also important following the 
ternary complex formation, since the aa-tRNA in the ternary complex is substantially 
distorted upon ribosome binding, allowing it to interact simultaneously with the mRNA 
codon and EF-Tumt (30).  
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Figure 4-14.  Interaction of T. thermophilus EF-Tu with aa-tRNA.  This 
image was obtained from the crystal structure of the T. thermophilus 
Phe-tRNA:EF-Tu:GDPNP ternary complex (PDB 1TTT).  The residue 
homologous to R336 is shown with its nitrogen atoms in blue.  The 
phosphate of G1 of the Phe-tRNA is shown in orange, with its oxygen 
atoms shown in red.  The tRNA is shown in dark gray. 
 
CONCLUSION 
 Oxidative phosphorylation requires the assembly of the electron transport chain and 
ATP synthase, which contain protein components synthesized by the mitochondrial 
translational machinery.  A defect in mitochondrial translation caused by the inability of EF-
Tsmt R325Q to bind to EF-Tumt likely leads to the defects in oxidative phosphorylation seen 
in the clinical manifestation of the EF-Tsmt mutation. 
The R336Q variant of EF-Tumt is inactive in mitochondrial polypeptide chain 
elongation as a result of its inability to bind mitochondrial aa-tRNAs.  Failure of ternary 
complex formation leads to defective mitochondrial protein synthesis, causing a decrease in 
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oxidative phosphorylation. One direct clinical phenotype of the EF-Tumt R336Q mutation is 
lactic acidosis (9), which most likely resulted from the buildup of lactic acid from pyruvate 
due to a failure in the synthesis of the respiratory chain. 
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CHAPTER 5 
 
THE EFFECT OF SPERMINE ON THE INITIATION OF MITOCHONDRIAL PROTEIN SYNTHESIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of the work reported in this chapter has been published (1) and reprinted with 
permission.
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Figure 5-1.  Structure of spermidine. 
INTRODUCTION 
Spermine and spermidine are aliphatic polyamines that have a number of roles in 
both prokaryotic and eukaryotic cells.  Both polyamines are cationic at physiological pH due 
to pK values >8 (2).  In prokaryotic cells, polyamines are known to affect protein synthesis in 
several ways.  The structure of the SD region on the mRNA is rearranged in the presence of 
polyamines, which helps promote the formation of the prokaryotic initiation complex (3).   
In addition to this structural effect, polyamines lower the optimal concentration of Mg2+ 
required for protein synthesis.  Translation initiation on the minor start codon UUG, used, 
for example, in the translation of adenylate cyclase, is stimulated by polyamines (4).  The 
tertiary polyamine spermidine (Figure 5-1) reduces the dissociation of 70S ribosomes, 
partially counteracting the action of IF3 in the initiation of translation (5).   Spermine, a 
quaternary polyamine (Figure 5-2), has binding sites on both 16S and 23S rRNA, indicating 
that it could be important for ribosomal structure (6;7).  Spermine crosslinks near the 
decoding center of the small subunit, suggesting that it could also be involved in aa-tRNA 
binding (6). 
In wheat germ, spermidine has been shown to affect translation by increasing the 
fidelity of protein synthesis (8).  Spermine exists in the cytosol of eukaryotic cells with 
concentrations in the µM range (9) and is known to be present in mitochondria although it 
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Figure 5-2.  Structure of spermine. 
is not synthesized there (10).  In fact, spermine plays a metabolic role in mitochondria by 
stimulating the activity of the pyruvate dehydrogenase complex and by activating citrate 
synthase in the citric acid cycle (10).  Because spermine binds to the mitochondrial 
membrane, the concentration of spermine inside the mitochondrion is difficult to measure 
accurately and is, therefore, not known (11).   
Spermine affects translation in mitochondria by lowering the Mg2+ requirement for 
the association of mitochondrial ribosomal subunits into 55S monosomes by about 1 mM 
(12).  Little is known about other effects that spermine may have on protein synthesis in 
mitochondria.  Because mitochondrial mRNAs are largely leaderless, the effects of spermine 
on mitochondrial translation may be different from those observed with prokaryotic 
mRNAs, most of which contain SD sequences. 
 
MATERIALS AND METHODS 
Materials 
General chemicals were purchased from Sigma-Aldrich or Fisher Scientific.  Bovine 
mitochondrial ribosomes (55S), ribosomal subunits (28S and 39S), and yeast [35S]fMet-tRNA 
were prepared as described (13-16).  Poly(A,U,G) was synthesized and purified as described 
(17).  The AUG triplet was purchased from Dharmacon.  A 29-mer RNA oligonucleotide 
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containing the 5’ AUG start site (underlined) for subunit I of bovine mitochondrial 
cytochrome oxidase, AUGUUCAUUAACCGCUGACUAUUCUCAAC, was also purchased from 
Dharmacon. 
 
Cloning, Expression and Purification 
Bovine IF2mt and human IF3mt were cloned, expressed, and purified as described 
previously (18). Both proteins required further purification following the Ni-NTA column. 
IF2mt and IF3mt were purified on DEAE-5PW and SP-5PW HPLC columns, respectively, as 
described (18). 
 
Dissociation of Mitochondrial 55S Ribosomes by IF3mt in the Presence and Absence of 
Spermine 
Mitochondrial ribosomes (8 pmol, 80 nM) were incubated in the presence or 
absence of IF3mt (41 pmol, 410 nM) and in the presence and absence of spermine (0.1 mM) 
in 100 L of gradient buffer containing 25 mM Tris-HCl (pH 7.6), 5 mM MgCl2 , 40 mM KCl 
and 1 mM DTT for 15 min at 37 °C. After incubation, reaction mixtures were placed on ice 
for 10 min and then layered onto cold 4.8 mL 10-30% linear sucrose gradients prepared in 
gradient buffer with and without spermine. Gradients were centrifuged for 1 h and 45 min 
at 220,000 g ave in the Beckman SW55 Ti rotor and fractionated as described (19). 
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Initiation Complex Formation on Mitochondrial Ribosomes 
Stimulation of initiation complex formation by spermine was examined by 
measuring the increase of [35S]fMet-tRNA binding to 55S ribosomes or 28S subunits in a 
filter binding assay.  Reaction mixtures (100 L) were prepared as described previously 
(16;20) and contained the indicated amounts of IF2mt and/or IF3mt, [
35S]fMet-tRNA (60 nM), 
0.25 mM GTP, 1.25 mM PEP, 0.9 U pyruvate kinase, 55S ribosomes (60 nM) and, unless 
otherwise indicated, 10 g poly(A,U,G). Mixtures were incubated for 10 min at 37 °C. The 
amount of [35S]fMet-tRNA bound to ribosomes was measured using a nitrocellulose filter 
binding assay (20;21).   
 
RESULTS AND DISCUSSION 
Effect of Spermine on Initiation Complex Formation on Mitochondrial 55S Ribosomes 
 In the absence of mRNA, fMet-tRNA is able to bind mitochondrial ribosomes to a 
limited extent (20).  Thus, the effect of spermine on the binding of fMet-tRNA to 
mitochondrial 55S ribosomes was tested in the presence and absence of mRNA, IF2mt, and 
IF3mt (Figure 5-3).  In the presence of both initiation factors and poly(A,U,G), a two-fold 
increase in fMet-tRNA binding correlated with increasing concentrations of spermine up to 
0.05 mM (Figure 5-3).   This result indicates that spermine has a positive effect on initiation.  
This effect could occur at one or more or several steps, including: fMet-tRNA binding, mRNA 
binding, the action of IF2mt, or the action of IF3mt.  
 If spermine primarily affects fMet-tRNA binding by promoting the interaction of the 
mRNA with the ribosome, one might expect a smaller effect of spermine on fMet-tRNA 
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Figure 5-3.  Effect of spermine on initiation complex 
formation using 55S ribosomes in the presence and 
absence of mRNA.  [35S]fMet-tRNA binding to 
mitochondrial 55S particles was tested in the presence 
and absence of poly(A,U,G) mRNA, IF2mt, and IF3mt at 
different concentrations of spermine as described in 
Materials and Methods. 
binding in the absence of 
mRNA.  Binding of fMet-tRNA 
to ribosomes was significantly 
lower in the absence of mRNA 
(Figure 5-3); however, 
spermine stimulated this 
binding two-fold, as observed 
in the presence of mRNA, 
although higher 
concentrations of spermine 
were required to observe this 
effect.  This observation 
suggests that spermine is affecting a step in initiation distinct from the mRNA binding step. 
 To further explore this conclusion, we have more fully examined the effects of 
spermine on initiation complex formation with three different mRNAs (Figure 5-4).  These 
mRNAs included the AUG triplet, a 29-nucleotide RNA derived from the initiation site of 
bovine mitochondrial subunit I of cytochrome oxidase, and poly(A,U,G).  The assays shown 
in Figure 5-3 were carried out using poly(A,U,G), a long RNA polymer that is not 
representative of natural mitochondrial mRNAs.  Native mitochondrial messages contain 
few or no nucleotides 5’ to the initiation codon, so the AUG triplet and the leaderless CoI 
mRNA were used. 
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Figure 5-4.  Effect of spermine on initiation complex 
formation using 55S ribosomes in the presence of 
various mRNAs.  [35S]fMet-tRNA binding to 
mitochondrial 55S particles was tested in the 
presence of IF2mt, IF3mt, and saturating amounts of 
poly(A,U,G), the 29-mer cytochrome oxidase start 
site, or the AUG triplet at different concentrations of 
spermine as described in Materials and Methods. 
 In the absence of polyamines, substantial binding of fMet-tRNA to the ribosome was 
observed with poly(A,U,G).  Spermine stimulated this binding nearly two-fold.  When the 
AUG triplet was used in initiation complex formation (Figure 5-4), less fMet-tRNA binding 
was observed in the absence of 
spermine, and this polylamine 
stimulated binding about three-
fold, bringing it close to the level 
observed with poly(A,U,G).  
Natural mitochondrial mRNAs 
are generally leaderless.  To 
examine the effect of spermine 
on a natural initiation site, we 
used a 29-mer synthetic 
oligonucleotide based on the 
initiation site of subunit I of the 
bovine cytochrome oxidase mRNA.  When this oligonucleotide was tested for initiation 
complex formation in the absence of spermine, it showed about the same level of binding 
as observed with the AUG triplet (Figure 5-4).  Again, spermine stimulated binding about 
three-fold. 
 The more substantial binding obtained in the absence of spermine with poly(A,U,G) 
probably reflects the ability of this long polymer to trap fMet-tRNA more effectively on the 
ribosome.  Long mRNAs are known to bind more rapidly to the small subunit and to 
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Figure 5-5. Effect of spermine on IF3mt-induced 55S 
dissociation.  [35S]fMet-tRNA binding to 
mitochondrial 55S particles was tested at different 
concentrations of IF3mt with and without spermine 
using poly(A,U,G) as the mRNA at a fixed 
concentration of IF2mt as described in Materials and 
Methods. 
dissociate more slowly than shorter mRNAs (22).  Since stable initiation complex formation 
requires the simultaneous presence of both fMet-tRNA and mRNA on the ribosome, the 
more stable binding of poly(A,U,G) to the ribosome allows more initiation complex 
formation to be detected in the absence of spermine.  Regardless, spermine stimulates 
fMet-tRNA binding in the absence of any mRNA (Figure 5-3) and in the presence of all the 
mRNAs tested (Figure 5-4), indicating that the effect of this polyamine on initiation is not 
directly on mRNA binding to the ribosome. 
 
Effect of Spermine on IF3mt-Mediated Stimulation of Initiation Complex Formation 
Another potential target for the effect of spermine is on the action of IF3mt.  The 
major effect of IF3mt on initiation 
complex formation is to loosen 
the interactions between the 
ribosomal subunits, making the 
small subunit available for fMet-
tRNA binding.  Since spermine is 
expected to tighten subunit 
interactions, one might predict 
that spermine would increase 
the amount of IF3mt required for 
initiation.  To test this theory, 
fMet-tRNA binding to mitochondrial ribosomes was examined in the presence of IF2mt with 
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increasing amounts of IF3mt (Figure 5-5).  In the presence of IF2mt and mRNA, the addition of 
IF3mt caused a 2-fold increase in fMet-tRNA binding in the absence of spermine (Figure 5-5).  
This stimulation is believed to arise because IF3mt promotes the dissociation of ribosomal 
subunits and, therefore, enhances initiation complex formation.  Surprisingly, the addition 
of spermine did not result in a need for a higher concentration of IF3mt to promote initiation 
complex formation.  In the presence of spermine, IF3mt increased the amount of fMet-tRNA 
bound to 55S ribosomes with basically the same dose response curve as observed in the 
absence of spermine (Figure 5-5).  Spermine caused a 1.4-fold stimulation of fMet-tRNA 
binding independent of the amount of IF3mt added.  This observation suggests that the 
effect of spermine is not directly on IF3mt. 
 In prokaryotes, spermine has been shown to change the conformation of the 30S 
ribosomal subunit to favor subunit association (6).  It also reduces the electrostatic 
repulsion between the subunits by masking the charges on the rRNA (23).  In both 
prokaryotes and mitochondria, spermine has been shown to tighten the interaction 
between the ribosomal subunits (12;24).  The effect of spermine on the ability of IF3mt to 
promote subunit dissociation was tested directly using sucrose density gradient 
centrifugation (Figure 5-6).  In the absence of both IF3mt and spermine, mitochondrial 
ribosomes existed primarily as 55S particles at 5 mM Mg2+, although a small amount of 
dissociation was observed (Figure 5-6).   The addition of spermine led to a stronger 
interaction between the ribosomal subunits, and very few subunits were observed in its 
presence.  In the absence of spermine, IF3mt was able to promote the dissociation of 
ribosomal subunits.  However, in the presence of spermine, IF3mt had almost no effect on 
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Figure 5-6.  Effect of spermine on IF3mt-induced 
55S dissociation measured using sucrose density 
gradient centrifugation.   Fractionation profiles of 
mitochondrial 55S ribosomes after centrifugation 
on 10-30% sucrose gradients as described in 
Materials and Methods. 
the dissociation of 55S ribosomes.  Thus, spermine appears to play a role in tightening of 
the interactions between the 
mitochondrial 28S and 39S 
subunits.  It is possible that, in the 
presence of spermine, IF3mt 
loosens mitochondrial subunit 
contacts enough to allow initiation 
complex formation but not 
enough to stably dissociate the 
ribosomal subunits.  This 
observation argues that the effect 
of spermine is not on the action of 
IF3mt in promoting ribosomal 
subunit dissociation. 
 
Effect of Spermine on the Action of IF2mt in fMet-tRNA Binding to 55S Ribosomes 
IF2mt is known to stabilize the binding of fMet-tRNA to the P-site of the ribosome 
and, as expected, the amount of fMet-tRNA bound to the ribosome was quite low in the 
absence of IF2mt (Figure 5-7).  However, even in the absence of IF2mt, spermine enhanced 
the binding of fMet-tRNA to the ribosome.  This observation is in agreement with the data 
above, suggesting that the effect of spermine is directly on fMet-tRNA binding to the P-site.  
The presence of spermine did not significantly alter the stimulatory effect of IF2mt.  As the 
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Figure 5-7.  Effect of IF2mt on initiation complex formation 
in the presence and absence of spermine. [35S]fMet-tRNA 
binding to mitochondrial 55S particles was tested with 
and without spermine at the indicated concentrations of 
IF2mt as described in Materials and Methods. 
IF2mt concentration was 
increased, considerable 
stimulation of fMet-tRNA 
binding was observed as 
expected.  However, the 
degree of stimulation of 
fMet-tRNA binding to the 
ribosome caused by 
spermine (1.6-fold) was 
constant at all 
concentrations of IF2mt.  
This observation suggests that spermine does not directly affect the action of IF2mt. 
 
Effect of Spermine on fMet-tRNA Binding to 28S Subunits 
 The data above demonstrate that the effect of spermine is on fMet-tRNA binding to 
the ribosome; however, the question arises as to whether spermine affects fMet-tRNA 
interactions on the small or large ribosomal subunit.  If fMet-tRNA binding to the small 
subunit is being affected, the same increase in fMet-tRNA binding should be observed on 
28S subunits as was seen on 55S ribosomes.  In the presence of increasing amounts of 
spermine, an increase in fMet-tRNA binding was observed in the presence of IF2mt (Figure 5-
8).  IF3mt was not needed in this assay, since no dissociation of ribosomal subunits was 
needed.  The stimulatory effect of spermine was absolutely dependent on IF2mt, reflecting 
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Figure 5-8.  Effect of spermine on initiation complex 
formation using 28S subunits in the presence and 
absence of initiation factors.  [35S]fMet-tRNA binding to 
mitochondrial 28S subunits was tested using poly(A,U,G) 
as the mRNA in the presence and absence of IF2mt at 
different concentrations of spermine as described in 
Materials and Methods. 
the lower stability of fMet-
tRNA bound to the small 
subunit alone.  However, the 
same two-fold stimulation of 
fMet-tRNA binding by IF2mt 
was observed on both 28S 
subunits and 55S ribosomes.  
Thus, the full effect of 
spermine was seen on 28S 
subunits and can be 
attributed to a direct 
stimulation of fMet-tRNA 
binding to the P-site of the small ribosomal subunit. 
 
Effect of Polyamines on fMet-tRNA Binding to Prokaryotic and Mitochondrial Ribosomes 
Polyamines have been shown to be important for prokaryotic translational initiation, 
and the current work demonstrates that spermine is also important in the mitochondrial 
translational system.  Because spermine was shown to crosslink to the decoding center of 
the prokaryotic ribosome, it was assumed that the effect of spermine could be on fMet-
tRNA binding to the SSU.  However, it was unclear whether the effect of spermine was 
primarily on the interaction of the tRNA with the rRNA or the proteins of the SSU.  The 
crystal structure of the T. thermophilus ribosome demonstrates that the P-site bound tRNA 
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has several important contacts with the SSU of the ribosome that could be affected by the 
presence of spermine (25).  Ten of those contacts are with rRNA nucleotides on the SSU, 
and those ten residues are present in the truncated mitochondrial 12S rRNA.  Spermine 
could enhance these interactions by shielding the repulsion between the backbones of the 
tRNA and the rRNA.  The tRNA in the P-site of the prokaryotic ribosome only interacts with 
one SSU protein (S13), which is not present in mitochondrial ribosomes.  However, 
additional protein contacts are made between the mitochondrial ribosome and the P-site 
tRNA (15).  An interaction occurs between the T loop of the tRNA bound at the P-site and 
the P-site finger protein, a structure unique to the mitochondrial system (15).   A further 
interaction is observed between the CCA-arm of the tRNA and an unknown small subunit 
protein.  These protein interactions, unique to the mitochondrial system, could also be 
enhanced by spermine. 
 
CONCLUSION 
 Initiation of translation in mitochondria is stimulated by the presence of spermine, a 
polyamine that occurs naturally in mitochondria.  The stimulatory effect of spermine does 
not appear to depend on the mRNA used, the action of IF3mt, or the action of IF2mt.  The 
data suggest that the binding of fMet-tRNA to the P-site of mitochondrial 55S ribosomes is 
directly stabilized by spermine.  This effect could be due to the alteration of the 
conformations of the ribosomal subunits by spermine or to a direct stabilization of the 
contacts between fMet-tRNA and the ribosome.  The observation that the full effect of 
spermine is observed on 28S subunits indicates that this polyamine is primarily enhancing 
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the interaction of the fMet-tRNA with the small subunit.  Future work regarding translation 
in mitochondria should carefully consider the spermine concentration used. 
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